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INTRODUCTION

Thyrotoxicosis is a frequently discussed medical problem which
has aroused the interest of not only the physician and the surgeon
but of the chemist and the layman a.s well.

It is a problem which

enters into every sphere of social and economic activity.

Hertzler

regards the disease as a life time process which after once occurring, runs its course in cycles subsiding c,nly to reappear with a
new manifestation.
The thyroid gland is probably the most important of the
endocrine glands.

Any abnormality of its functional bala..~oe

produces more physical and mental ailments than any other medical
problem.
Probably the greatest advances in medicine have been in the
field of endocrinology.

The ~~rk that has been done on the thyroid

alone since 1910 constitutes a brilliant chapter in the history of
medicine.

But in spite of this, there still exists some uncertainty

as to the diagnosis of thyrotoxicosis, and even more uncertainty
with regard to its treatment.
The accepted treatment has been surgical following preoperative
preparation with iodine, arl. rightly so. surgery has produced more
satisfactory results than any other type of treatment undertaken.
There is a feeling, however, even among the surgeons that the
fundamental cause of the disease is not being treated by a thyroidectomy

and that the ultimate results of suoh treatment ere uncertain.
With a di soovery of drugs which seemingly -oo ssess ability to
inhibit the thyroid glend~ a new interest has been revived in the
thyroid and in the treatment of thyrotoxioosis.
The purpose of this thesis is to review the whole problem
of thyrotoxicosis; to evaluate the factors invorved in its production and to summarize the methods of its control including
thiouracil.
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D E F I N I T I ON

DEFINITION
Thyrotoxicosis is a gener~l systemic state which simulates the
effects of overdosage with thyroid secretion.

It covers a number

of clinic el and pathologice.1 anti ties, and is synonymous with
hyperthyroidism and toxic goiter.

The term applies to Grave's

disease, exo?hthalmic goiter, primary hyperthyroidism, or diffuse
toxic goiter; Plunrrn.er 1 s disease., secondary hyperthyroidism, or
toxic adenoma; and to mixed types of toxic goiter,

Many investi-

gators (60.,84,100,128,133,181) believe the underlying pathology
of both the exophtha.lmic g;oi ter and toxic a.c',enoma. to be the same.
Any differences noted are due to variations of an individual
patient in response to thyroid intoxice.tion.

This point of view.,

however, is not altogether shared by others (71,144) viho maintain
the.t the disturbance in the exophthalmic goiter and toxic adenoma
differ fundamentally.

The latter believe that in exophthalmic goiter

the gland reacts with hyperfunction elsewhere in the body, possibly
in the vegetative nervous system, while in toxic adenoma, the
disturbance is primarily in the thyroid.

This point of view is

based principe.lly upon clinic al observation that patients with
exophthalmic goiter react differently to iodine, as well as, on the
basis of physiologic&l and surgical reactions. (19)

Bram (25)

classifies toxic adenome. as a. neoplasm which is amenable only to
surgery.
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GE OGRAP HI C DI S T R I B UT I ON

GEOGRAPHIC DISTRIBUTION
The first extensive study on the geographical relation of
thyrotoxicosis in the United States was me.de by Crotti (48) who
reported an incidence in 2,510,791 soldiers drafted from the entire
country durin~ the World War I.

There were 8,647 cases of thyro-

toxicosis in this grou~ and to a. large extent represented the
Northern states.

The Southern states were comparatively free from

toxic goiter.
Eggenberger (58) points to the maps of Love and Davenport (107)
to substantiate his observations in S"l'ritzerland, as well as in the
United States that thyrotoxicosis is closely bound vrith the notorious goiter regions. (Figs. 1 & 2)

The observation was confirmed

by other observers (32,122) ¥iho Rttribute the close relationship
between the two entities a.s due to iodine starvation.
asserted (58,122) that

~,n

It was

increased ingestion of iodine serves not

only in the prevention of siF~le goiter but also to diminish the
incidence of thyrotoxicosis.

Means, (128) Berry, and Eberts on

the other h0nd do not share this opinion.

They sey that while

simple goiter has a definite geogre:phic distribution which closely
corresponds with iodine deficiency in the soil and drinking water,
such a distribution of cases of thyrotoxicosis has a far less
definite g;eog;re.phica.l conf'igurs.ti:m.

They point out that there

is an abundance of thyrotoxicosis in regions which are nonendemic.
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As to the relation of a region to frequency and severity,

Thompson and Means studied exophthalmic goiter in Boston, a nonendemic area., and Chicago, an endemio area.

The initial height

of metabolism, the amount and rate of reduction under iodine, and
the sex ratio were used as criteria of severity of thyrotoxicosis.
No significellt difference was found in severity of the disease
on the basis of eIJ.Y of the above criteria.
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INCIDENCE

INCIDENCE
AGE OF ONSET

Diffuse toxic goiter me.y occur at any age from the infant
in the arms to the man or woman of 80. (130)

The disease occurs

most frequently, however, in the third decade of life.

The in-

oidenoe rises sharply after puberty, declining during the fourth
decade., and there is e. tendency to rise e.gain during the fifth
decade.

The latter probably is associated with the menopause. (73)

Thyrotoxicosis in children up to 14 years of age is comparatively rare.

Dinsmore (52) reported 124 oeses, 105 of whom. were

girls and 19 were boys.

1:
I

Crile (44) reported five oases occurring

under the age of 5 years or an incidence of one in 6,670 adult
!.

cases.

He states that exophthe.lmos is much more common in children

with thyrotoxicosis than in adults.

Elliott reported a ce.se of a

two and one-half years old female with exophthalmos and all the
other symptoms of thyrotoxicosis.
The onset is reported (108) to be much later in well-to-do
classes, and that in men it often begins later than in women.

A

statistical study (73) of 400 thyrotoxic goiters in the Pacific
Northwest shows the age incidence to be apparently higher than for
the country at large.

The average age was found to be 38 or in

the fourth decade of life rather than the third ~s ~iven in most
1:

statistics.

f
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Thyro-coxicosis of e.denoma.vous origin has a tendency to
occur in the age group above 40 yea.rs.

The difference in the age

of' onset is s-cill more mar·ked among the male pa-cients.

Plummer

estimated vhd in pa1.,ients in the Me.yo Clinic 14+ years elapsed,
on the average, from the time of appearance of nodular goi te.t· and

1

the onset of' symp1.,oms.

Likewise, the sympvoms were less marked

than in exoph,:;he.lmic goi te.1..

He estimated 1..,he symptoms in exoph-

thalmic goiter to appear at an average age of 32.9 years while the
enlargement of Ghe thyroid had been noted a.t an average age of 32
yea.rs.
SEX

The sex ratio of thyrotoxicosis varies considerably in 1,he
different parts of -che country.

Women a.re much more commonly

aff'ected than men.

In the Pacific Nor1.,hwest 1..,he re-cio was reported

to be b to l. (7~)

Means (128) reported a ratio of' 4 to l in e.

nonendemic area, and 4 to 3 in Michigan which is an endemic area.
In the Mayo Clinic (155) the ratio was almost 6 to 1 while Crunpbell
reported a 7 to 1 ratio in Ireland.

He also states that childless

married women and unmarried women are more susceptible ·chan those
who have borne children.

RACE
The disease is b~lieved to affect members of any race or
society.

It is observed in 1.,he f'air haired, blue e.Yed whites;

dark ha.ired, dark eyed whites; in Negroes, and Orientals al1.,hough
it is stated -cha0 the disease is re_re in the two latter g1·oups if
8

they remain in their own environment.

Donni son holds that

thyrotoxioosis, of ell clinical entities, is lllOst intimately
linked with civilized society.

He claims never to have observed

e. case in an African native and has been able to find but a

single case recorded in the literature.

He goes on by saying

that the disease is not mentioned in the accounts of natives in
China or South Africa. and that.it is uncommon in Celon.
other hand, it is not unconnnon in the Americsn Negro.

On the

Means (128)

states that the disease was observed among the natives in certain
areas of the Belgian Congo.
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ETIOLOGICAL

FACTORS

----,1

ETIOLOGICAL FACTORS
Those who have studied the thyroid gland and its diseases
agree that the etiology of thyrotoxicosis is still a mystery in
spite of much speculation, observation, and experimentation.

HEREDITY
Heredity may play only a minor role in its production, although a survey of literature shows frequent references to this
a.s being a. factor of some importance. (36.,4,8,128,131)

Cookayne

considers exophtha.lmic goiter itself as not being hereditary.

He based his belief upon the fa.ct that (a) the disease is seldom
pres~nt at birth, and (b) the age at ~~ich it occurs is variable,
frequently occurring in children of healthy pa.rents and without
any family history of the disease.

However, it is his impression

that constitutional weakness of the thyroid may be hereditary and
explainable on a Mendelian basis.

ENVIRONMENT
Whatever is attributed to heredity is cert~nly difficult
to separ&te from environmental conditioning.

The individual's

pattern of activity becomes habitual with time.

Faulty early

conditioning is believed to lead to a. feeling of disharmony with
the environment.

The striving to compensate for frustrations

10

may result in thyrotoxicosis.

In general, thyrotoxicosis is

believed to be only one expression of mal-adjustment of the entire
individual. (140)
Wartin is certain that the thyroid is not the whole story~
and not the primary pathogenic factor.

He holds thyrotoxioosis to

be nothing more than a pathologic reaction predetermined in the
individual by virtue of his constitutional anomaly.

Development

of thyrotoxicosis is but an expression of an abnormal reaction of
this anomaly to conditions of life.

He prefers to apply to this

type of constitution the term. "Grave's ConEtitution!'.

Individuals

belonging to this ca.ta.gory were characterized by a youthful build
with a slender, delicate sof't skeleton. slender waist~ long thin
fingers, toes with pointed terminal phalanges, increased articular
mobility. abundant hair, and well developed teeth and nails.

Mor-

phologically this type of en individual presents elements of ideal
bea~ty.

Fitz

also attempted to classify individuals developing

thyrotoxicosis and observed the disease in both tall and short,
fat and thin, and in old and young.

He declares that the term

•Grave's Constitution" is not altogether reasonable.

NERVOUS
A study of histories of patients with thyrotoxicosis led
Kissel, Lieb, and Hyman to think that a disturbance of the
inv?luntary nervous system may play an important etiological
role.

When

there is an imbalance existing between the sympathetic

and parasympathetic nervous systems, a lack of autonomic control
11

may produce an overstimulation or the pituitary gland which in

turn by its hormonal control stimulates the thyroid to overactivity
and symptoms of toxicity.

This was demonstrated by administering

adrenergic and cholinergic drugs to experimental animals which
developed some of the symptoms of thyrotoxicosis.

Cannon and

associates were able to produce a syndrome similar to Grave's
disease together with hyperplasia of the thyroid by fusing the
phrenie and cervical sympathetic nerves in cats.

They found the

adrenals were also hypertrophied to about three times the normal
weight.

Histological sections revealed the increase to be confined

chiefly to the cortex, but its significf.lllce is not entirely clear.
According to Maranan a minute dose of epinephrine injected
into a person with a hyperf'unctioning thyroid, induces tremor,
pallor, palpatation, chilliness, lacrimation, and voiding of urine,
an organic phenomena such as may accompany emotional stress.

This

reaction does not occur in a normal individual, unless a much larger
dose of epinephrine is employed.

It does occur, however, exactly

as in hyperthyroidism if the subject is given a large dose of
thyroid extract previous to the injection of epinenhrine.
EXCITING
There are those who point out numerous exciting agents.

The

literature contains frequent references to infections, overdrugging,
anxiety, worry, mental stress, shook, and ad infinitum as being
exciting factors in thyrotoxioosis.
From experiments on goats, Wilson (194) found that irritation
12

from certain bacteria. within the cervical sympathetic ganglia
may produce a histologioal picture both in the ganglia, and in
the thyroid whioh closely parallels that f,:mnd in the various
stages of thyrotoxioo·sis.

Studies (193) have substantiated the

existance of various degrees of pathological changes in cervical
sympathetic ganglia following sympathectomies in thyrotoxic patients,
but it yet remains to be proved that this change wa.s associated
with infection.
The literature records infections of the mouth and teeth (139)
tonsils, and sinuses (183)as being stimulating factors in some
oases.

Evidence indicated that removal of these foci of infection

led to subsidence of symptoms.

Webster insists that all focal

infections should be removed before attempting surgery on the
thyroid, or as soon as possible thereafter.

In his opinion thyro-

toxic patients, especially those with a diffuse goiter, have a
low resistance to pyogenic infections.

Recurrences following

thyroideotom:y are largely attributed to this factor.
Graham found 84 per cent of the patients with some degree
of tonsillar infection while in a similar number of case histories
selected at random representing a general run of patients,, 52 per
cent showed some tonsil infection.

Dental caries were second on

the list with 24 per cent among the thyrotoxic patients.

Nervous

exhaustion, neuritis, gallbladder disease, chronic nephritis, lues,
and diabetes represented lesser per cents.

Plummer and Mayo ex-

press an opinion that patients ~dth thyrotoxicosis are prone to
have tonsils from which fluid can be expressed.
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They state that

it was a consensus of opinion that infections of various forms
as cited in the literature are non-specific since infectious
processes have never been proved to affect the thyroid gland
directly or indirectly.
It was observed (146) that in certain portions of the upper
Mississippi Valley, and Great Lakes region incidence of toxic
goiter, epidemic in proportion, occurred in waves.

It was noted

that following the influenza epidemics of 1898 and 1918 there
was a higher incidence of thyrotoxicosis.

However, the evidence

is only inferential in nature.
Weight reducing measures may precipitate thyrotoxioosis. (129)
Means (128) collected a total of 16 cases in which the disease
followed a regime for weight reduction.

In 14 of these it was

dietary, while in 2, dessicated thyroid was employed in addition.
The story was that after adequate weight was lost, the therapy
was abandoned, but the loss of weight continued.
Reports of thyrotoxicosis developing f~llowing surgery of
various types a.re frequent even in the recent literature.

Aooord-

ing to Forbes these individuals were predisposed to the disease
e.nd the surgical procedures were only precipitating factors.
Worry, anxiety, fear, end other emotional reactions may play
a part in the production of thyrotoxic conditions. (15,41,121,128,132)
At the New York Hospital (81) in a 14 year period from 1915 to 1929,
only 20 men were trefl_ted for thyrotoxicosis, while in a 3 year
period from 1929 to 1932 26 men were treated.

This was far beyond

the usual female-ma.le ratio of 4 to l, showing that the depression

14

with its concomitant worries end insults wes too much even for the
unusually sturdy male.

Bram reports 90 per cent of thyrotoxio

patients with a history of psychic trauma.

Fear of pregnancy e.nd

childbirth combined with intense repressive emotion against men
may well serve to explain the greater incidence of toxic goiter in
women.
Crile (41) relates that the phenomena of fear, worry, and nerve
strain are nearly identical with that observed in thyrotoxicosis.
Fear is the strongest emotion.

This can be elicited only in animals

that utilize a motor mechanism in defense against danger.

It is

expressed by pal pi te.tion of the heart, alteration of respiratory
rhythm, cold sweat, rise in blood pressure and body temperature,
tremor, pallor, protrusion of eyes, and sus~ension of brain function
except as relating to protection.

Man in civilized society is said

to be in autocaptivity with much restraint, little action, and

.

much emotion, symptoms of which are similar to those which can be
produced by e.dministration of thyroid extract •
However, Hauser s~ys that if emotional shock, anxiety, and
worry were the only causative factors, all would be victims of this
disease.

Means (21) and Hertzler look upon psychic traumas only

as an incident which calls attention to e. pre-existing condition.

ENDOCRINE
Much experimental work has been directed toward the endocrine
system as being somehow related to the production of thyrotoxicosis.
'.!:he literature is a voluminous maze of unrelated material and
15

contains a great deal of controversial subjeot matter.
The thyroid is bown to be subordine.ted to the anterior
pituitary glend, and it is believed to be intimately related to
other endocrines either directly or indirectly, and possibly to
the nervous system.
Investigators (121,166,170) have known for some years that
ablation of the anterior pituitary in experimental animals resulted
in a functionally inactive thyroid, end that its restoration could
be accomplished by either homotransplants ot" anterior pituitary
tissue, or intre.peri tonea.l injections of fresh anterior lobe extract of bovine hypophysis.

Thyroid hyperplasia and hypertrophy

was likewise produced in both hypophysectomized and normal animals
by injections of anterior pituitary extract.
Crew and Weisner found the isolated thyrothropic hormone from
the anterior pituitary to exert e. specific e.ction on the growth
and function of the thyroid gland.

Loeb in 1932 reproduced in a

guinea pig all the principal symptoms of thyrotoxicosis.

However,

he admitted and it was confirmed later by Collip and Anderson that
the thyroid glend returned to normal and all of the toxic symptoms
subsided in spite of continuation of injections of the thyrotropic
hormone.

HypophyseotoIT~zed rats were found to develop a similar

resistance.

Loeser in 1936 demonstrated that the refractoriness does

not appear if continuously increasing doses of thyrotropic hormone
are administered to guinea pigs.

He succeeded in producing all

the signs of thyrotoxicosis in his experimentie.l animals.

In addi-

tion~ Oollip demonstrated the thyrotropic hormone to be ~~thout
effect in G.thyroid animals.

16

Lately Griesbach has shown a cellular change occurring in
the anterior pituitary

characterized by increased basophilia

when there is an interference with the function of the thyroid
gland.
Al though definite proof hes been established for the relation

of the anterior pituitary to the thyroid, the process that initiates
the symptoms of thyrotoxicosis is not known.
Experiments of Marine and associates (115,116) have led them
to advance e. hypothesis thfat in thyrotoxicosis the fundalllental
di sturba.nce is due to primary insufficienc;r of adrenal cortex.

The

loss of control over the oxidative processes occurring in deficiency
of function in the supra.renal cortex might result in physiologic
attempt at compensation by overproduction of thyroid hormone,

They

found that by destruction or partial destruction of adrenal cortex
in animals ~~th intact thyroids resulted in a definite increase
in heat production, and other symptoms resembling thyrotoxicosis.
They corroborated the experimental data with case histories of
patients who showed consistently beneficial results to administration of supra.renal cortex extreot.

However, Marine ad.mi tted failing

to find any lesions in adrenals in association with thyrotoxicosis.
The interrelationship between the thyroid and the gonads is
often demonstreted by an abrupt menopause during exacerbation of
thyrotoxicosis; (154) by the influence of ovariotomy on iodine in
the thyroid and blood; and by changes in iodine metabolism which
occur

at different functional periods of the ovaries during men-

struation, pregnancy, and menopause. (90,101)
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In cretinism and

I!
!

myxedema sexual development and functions e.re definitely retarded.
Likewise after castration there occurs a slow involution of the
thyroid with a lowering of the basal metabolic rate.

Both hyper-

thyroidism end hypothyroidism are frequently associated witr
amenorrhea.

Hypogeni tal functions may be t,t times corrected by

thyroid substance. (49)
Injection of estrogenic substance into normal animals over
a prolonged period of time was shown to produce atrophy of the
thyroid with flattening of epithelium and increase in the colloid
matter. (143)

In this connection, it is interesting to note the

report of Goldman end associates (66) covering 8 oases of thyrotoxioosis arising ~~th menopause end which responded to estrone
therapy.

Evidence was shown that lerge doses of estrogenio sub-

stance have an inhibitory effect on thyroid either directly or
indirectly.
A relation of the thyroid to the pencree.tic hormone was pointed
out by Crile (43) who presented a series of 166 cases of diabetes
associated with hy-perthyroidism.

Either a complete cure or abate-

ment of the diabetic condition was brought about in 55 per cent of
these oases after thyroidectomy.
by Burns e.nd ?,forks.

A further relationship was shown

They demonstrated a. diminished hyperglycemio

reaction to e.drenaline and an incree.sed hypoglycemic reaction to
insulin following thyroidectomy.

Thyroid feeding was found to

increase hyperglycemia reaction as long as the glycogen supply in
the liver was not exhausted.
The thyroid-thymus interrelatbnship appears to be that of
antagonism.

In many instances of thyroto:dcosis, there also occurs

18

an enlargement of the thymus gland. (113.114)
its involution. (118)

Thyroidectomy hastens

The atrophic thymus has been shown to re-

generate following feeding of desiccated thyroid. (113)

The sig-.

nificance of this relationship is not clear, and remains to be
determined at some future time.
'rHYROIGr.'NOUS

It would be a serious error to overlook the possibility of an
intrinsic abnormality of the thyroid as an etiological factor in
the production of thyrotoxicosis.

It is entirely plausible that the

hyperactivity could be a disease from the first to the last, a
disease peculiar to the thyroid gland.

According to Hertzler, sur-

gical treatment of toxic goiter has produced an abundant proof to
establish this fact beyond controversy.

One can also presume that

the present day roentgenologist would me.ke an identical assertion
after clinical observation of a thyrotoxic patient responding to
treatment directed to the overfunctioning thyroid.
Wilson and Kendall me.de a comparative study of the iodine
content in the hyperfunotioning gland end in normal controls, and
were the first to prove the amount of thyroxine-iodine in the
thyrotoxic gland to be one-fiftieth to one-twentieth smaller than
in a norm.el gland.

Likewise, they discovered a restoration of

iodine content with regressive hyperplasia.

They interpreted the

findings as proof of the theory that thyrotoxioosis was a result of
overfunctioning end overelimination of its hormone into the blood
stream.

The findings of later workers (50) who investigated the

19

blood iodine 1~vel in thyrotoxicosis 6 hypochyroidism, and cretinism
support the earlier findings.

In thyrotoxicosis, blood iodine was

consistently elevated while in hypo·chyroidism and in cretinism iii
was persistently low.

Urinary excretion of iodine in thyrotoxicosis

was likewise found to be above normal 1~vels.
Altered secre~ion of chyroid hormone has been considered. as
a possible ca.use of ,:;hy~o-coxicosis.

the problem has both its

proponents (79~120) and opponents (1) so chat at pres~n,:; the whole
ques~ion is in an unsettled state because experimental work has
produced considerable vaiiation in results.
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SYMPTOMS

According to Means (128) the symptomatology of any case
depends upon the preclinical psychosomatic nature of that person.
"we do not all look or act alike when drunk., nor when thyrotoxic.
The nature of symptom picture is dependent not a.lone on the action
of the toxin but upon the personality., constitution, and reaction
pattern of the subject.tt

Since thyrotoxicosis affects every

tissue and organ of the body, inducing in ea.ch an increased e.otivityt one can expect variations in degree and sequence of occurrence

of the symptoms.

These are characterized by:

Goiter
Cardio-Vascular signs
Heart enlargement
Pa.lpata.tion and throbbing
Tachycardia
Auricular fibrillation
Cardiac decompensntion
Nervousness and emotional instability
Exophthe.lmos
Increased basal metabolic rate
Increased appetite
Loss of weight
Loss of strength
Nausea. and Vomiting
Diarrhea.
Prespire.tion
Amenorrhea
Fever and heat intolerance
Thrills and bruits over the thyroid
Decreased serum cholesterol
Increased excretion of ce.lciu..-rn end iodine
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GOITER
The presence of a goiter is often considered a classical symptom
of disease.

However, it is pointed out thE\t this is not dways

demorstr;;.,ble, and a olinici=dly demone':;!'able goiter ls not a sine
qua non in the diagnosis of thyrotoxicosis.

Many cases of disease

have come to Tucker's attention without either a visible or a
palpable thyroid gland.

He reminds his readers that a brief' study

of the anatomy of the neck will show how a fairly enlarged goiter
can conceal itself behind the structures found in this region.
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Fig. 3

Diagramatio drawing of fasciae of head and neck.
Saggi tal section.
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From Grodinsky

Normally the gland consists of two symmetrical lobes which are
connected in their lower third by an isthmus.

It is situated in

the lowermost portion of the neck anteriorly opposite the third
and fourth tracheal rings as a horseshoe.

The entire gland is

enclosed in a capsule of connective tissue "\llrhioh is continuous on
one hand with the septa that pass from the deep surface into the
substance of the gland, and on the other with visceral fascia by
·which it adheres to the trachea.

PRE VERT. F.
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Fig. 4

Diagram.a.tic drawing of fascia of the Neck.
Transverse section approximately at
the level of 6th cervical vertebra.
From Grodinsky
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Its weight and size varies with indiViduals# depending upon
habit, age, sex, and other circumstances.
heavier in the female than in the male.

The gland is usually
The weight as a rule ha.s

no relation to the size of the individual. (48,133)
Anatomically, the gland can enlarge posteriorly to enclose the
trachea, inferiorly to become hidden behind the sternum, and
anteriorly to give a typical clinical goiter, or to be masked by
the structures anterior to it.
There is a difference in the syndrome of exophthalmic goiter
and toxic adenoma which should be kept· in mind.

As Plunnner (145)

and Jackson point out, the onset of thyrotoxicosis with exophthalmic
goiter is much more abrupt than that with the adenoma.tous goiter.
A number of years elapse as a rule between the appearance of
goiter and onset of symptoms of toxicity with the latter while in
the former, the interval of time is a matter of months.
Even though the thyroid gland is not enlarged, it might be
firmer than normal which is an important clinical finding especially
when it is associated with bruits and thrills over one or both
superior poles.
The production of bruits is directly related to a marked
increase in the vascularity of the gland.

Normally~ the thyroid

is 28 times as vascular as the head and over five times as vascular
as the kidneys.

The blood supply is derived bilaterally from the

superior thyroid artery, a branch of the external carotid; the
inferior thyroid artery, a branch of the subclavian; and in 10 per
cent of cases from thyroidea ima which arises from the innominate
24

to end in the lateral lobes. (75)

In thyrotoxicosis, the circula-

tion is said to present a maelstrom which is not approached in any
other tissue or organ, and perhaps is equalled only by circulation
of arteriovenous aneurysm. (43)
The term exophthalmic goiter is definitely a misnomer.

Thyro-

toxicosis may be present either with or without any signs of exophthalmos.

Means (128) failed to find any eye signs in about

50 per cent of the cases with diffuse toxic goiter, but has found
the eye signs present with some of the cases with toxic nodular
goiter.
CARDIO-VASCULAR

Cardio-vascular symptoms and signs are often the first to
appear. (73)

The most collllll.on of these is sinus tachycardia.

The

heart action is forceful, and may be accompanied by a vibration of
the chest wall, producing a pseudo-thrill.

The increase in the

heart rate is proportional to the elevation of metabolic rate.

A

twenty per cent rise in metabolism was found to produce a 94 per
cent increase in blood flow, accompanied by a rise in both rate
and stroke volume of the heart.

A basal metabolic rate of

♦ 65

imposed the same burden upon a heart as a blood pressure of 200 :mm.
of mercury.

Aside from the basal metabolic rate, the heart action

is the best olinioe.l guide to the severity or the toxic state. (127)
The heart rate ranges from 90 to 120 beats or more per minute.
The rate is not readily influenced by rest.

The patient often

complains of dyspnea, palpitation, precordial distress, and of
throbbing sensation in the ears~ neck, and abdomen.
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Aey slight

exertion markedly increases the heart rate.
The apex beat is diffuse.

Sounds are loud, especially the first

sound at the apex which is often prolonged.

General systolic

murmurs may be heard over the precordium, commonly at the apex,
or in the pulmonic area, and less commonly at the aorta.

There is

usually no diastolic murmur at the base, but it may be present.
Pulse is large and there may be an exaggerated pulsation of peripheral
vess°-ls.

The diastolic pressure is high whereas in aortic in-

sufficiency, it is low.

(136 1 192)

The presence of thyrotoxioosis must always be kept in mind
when there is an enlargement of the heart, unexplained auricular
fibrillation, and cardiac deoompensation for this is not an infrequent complication, (55) particularly when the disease is of
long duration.
Auricular fibrillation is reported (191) to occur in about
20 per cent of the oases with practically the same frequency in both
exophthalm.ic and toxic nodular goiters.

At first it tends to come

in paroxysms, and is transient in hature, 1 at er it becomes permanent
with congestive heart failure often supervening. (27)

A study ma.de

by Nieha.use (136) shows the frequency of occurrence to be highest
in the fourth and fifth decades of life which is in agreement with
the figures of Hamilton.

NERVOUS
The nervous symptoms in thyrotoxicosis are characterized by
insomnia, emotionalism, irritability, excitability, fine tremor,
and a peculiar type of restlessness whioh is described as a
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purposeful movement without a puroose.

The petient may be grouchy.

have sudden fits of weeping, or display fearfulness as of some
impending doom.

Yet, the patient never loses hope and is never in

despair. (81,154,177)
Anxiety states may often simulate the symptoms of thyrotoxicosis,
and may present problems in differentiation.

However, anxiety

states are characterized by restricted drive, fatigue, coarse
tremor, cold, clammy skin, normal or slightly elevated basal metabolic rate which returns to norm.al durin~ sleep, pulse rate which
decreases during rest, and a loss of appetite.

Correct interpre-

tation of illness frequently can be ma.de from a carefully ta.ken
history whioh should inolude the presenting complaints as ,·;ell as
the patient's background and conflicts. (18)

EYE
Exophthalmos is not always a symptom in thyrotoxicosis as it
has been previously indica.ted. (81,128)
be either unilateral or bilateral.
be very great.
sockets.

When it does occur it may

The degree of protrusion may

The eyes may even become displaced from their

Bulging eyes alone do not make a diagnosis in exophthalmic

goiter since they are frequently found as a family trait.

Prominence

of the eyes may al so be associated w:i. th myopia., bra.in tumors, tumors
of the orbit, Bright's disease, and hemorrhage into the orbit.

The

three important signs of exophthalmos are: (a) widening of the
palpebral fissure or Stellwag's; (b) incoordination between the eye
ball and the lid as the patient glances downward or von Grafe~s; and
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(o) lack of power of convergence or Moebius.

The la.st two are of

particular importance because as exophthalmos increases, the movements of the various extra.ocular muscles become impaired thereby
producing abnormalities in the movements of the eyes. (154,177)
In the absence of true exophthalmos, the most pathognomonio sign
may be a stare which cen be observed best from the foot of' the bed.(81)

BASAL METABOLIC RATE
The basal metabolic rate is an important laboratory criterion
of the function and fluctuation of thyroid activity in diagnosis
and treatment of' thyrotoxicosis as long as the results of carefully
made tests by a competent technician harmonize with the hi story and
clinical findings.

A single determination cannot be relied upon

since errors in mechanics, computation, and preparation of a patient
can easily lead to a false conclusion.

Emphasis is me.de of the

necessity of obtaining a rate higher than a+ 15 before making a
diagnosis. (81,88,177)

Furthermore, thyrotoxicosis is not the only

disease associe.ted with en increase of basal metabolic rate.

The

following conditions likewise may produce an increase in basal
metabolic rate. (177)
1.

2.
3.
4.
5.
6.
7.

B.
9.

Drug administration
(a) thyroxine or desiccated thyroid
(b) adrenaline, oe.f!'eine, e.trophine, camphor, sulfa
drugs and others.
Inges~ion of food
Exercise
Pregnancy
Essential hypertension
Cardiao decompensation
Ac romegely
Febrile diseases
Blood dyscrasias
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The pronounced loss of weight which often equals one-third to
one-half of the body weight is associated with the aooelerated
metabolic processes.

The patient exhibits a voracious appetite,

but the caloric intake is usually insufficient to equalize the
energy expenditure.

Fever in varying degrees, prespire_tion, muscle

weakness, and fatigue may be very prominent symptoms.

The patient

may complain of inability to walk up e flight of stairs or to do
simple household tasks.

The weakness of quadriceps can be demon-

strated by the difficulty of stepping upon a chair. (22)
The patient me.y also complein of nausea and vomiting, ebdominal
pain and die.rrhea along with an increased appetite, but these symptoms
usually appear late in the course of the disease.
Means and associe_tes (129) suggested that thyrotoxicosis may be
associated with vitamin end minere.l deficiencies for needs increase
in proportion to the metabolic rate.

An individual may receive

adeauate amounts during health, but develop a deficiency during
disease.

However, they point out, adequate doses of vitamins produce

no effect upon the basal metabolic rate.
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THE

NORMAL

GLAND

THE NOIDI.A.L GLAND

In order to understend pathology of the thyroid gle.nd in
thyrotoxicosis., it is important to consider its origin, histology,
-

e.nd function in its normal state.
EMBRYOLOGY

The primordium of the thyroid gl end makes its appearance with
the first pharyngeal pouch as en evagination of epithelium in the
ventral wall of the pharynx.,

By the end of the fourth week of

fet8l life, it develops into undifferentiated, structureless mass
of cord cells.

Discontinuous cavities begin to form in the beaded

portion of the solid thyroid plate by the end of the eighth week
of' fetal life and these soon acquire che.re.cteristio oolloid.

l>y

the end of the fourth month., this conversion into follicles ends,
and thereafter new follicles form by a process of budding e.nd

subdivision from those that are already pr~sent. (48.,133,137)

HISTOLOGY
Thyroid parenchyma consists of follicles filled with colloid,
and small amounts of interfollioular connective tissue.

The follicles

are closed cavities lined by cuboidal epithelium, the shape of which
varies with age, end the phase of ~otivity of the gland.

Each

follicle represents the ultimate histological unit of the gland 1
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and whether large or smell, contain colloid material. (159)
Sometimes there are deseribed emall collection of cells, the
embryona.l rests of Cohnheim, between the follicles.

These epithe-

lial cells a.re supposed to remain dormant in most persons, but
are believed by som~ to give rise to thyroid adenomata. (65)

How-

ever, Reinhoff denies that there is such a thing as interfollicula.r
epithelium.
The individual folliole oells form essential factors in the
thyroid physiology end pathology.

It is these cells which undergo

changes with increased thyroid activity.

The epithelial cells
f

lining a normal follicle are cuboidal, possessing a clear cytoplasm

I

and basally located nuclei.

j,

t

PHYSIOLOGY

!

The thyroid gland is essential for growth, development., end
functional ca.pa.city of body tissue.

f

!

Its developmental arrest in

youth affects the skeletal, nervous, reproductive, and other systems
J1

of the body, end leads to cretinism.

In adults, its removal is

followed by symptoms of myxedema characterized by increase in

I

fi
i

weight, alteration of features, non-pitting edema. or the skin, loss
of hair, chronic constipation, increased sensitivity to cold, and
mental deterioration.

(92,133)

Gudernatsch demonstrated the growth factor in the thyroid gland
by feeding thyroid to tadpoles which developed. hind legs 9 days
after the feeding began, and fore legs two days later.

In the

control group several weeks elapsed between the appearance or the
hind and fore legs.

Likewise, thyroid fed tadpoles completed their
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metamorphosis in 18 to 20 days whereas normally it takes 10 to 12
weeks.

i:

~

'I

Dubois in 1916 demonstrated specific action of the thyroid
hormone upon the tissues of the body.

He found a high basal meta-

:I
!1

II
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bolic rate in thyrotoxic patients and a low basal metabolic rate
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in cretins and sufferers from myxedems. as a constant factor.
The thyroid gland is a storehouse and laboratory of iodine
compounds which influences the metabolic processes of the body.
Baum.en in 1895 isolated iodine in combination with thyroglobulin
from the thyroid gland.

Kendall's investigation of products of

hydrolysis of thyroglobulin in 1914 6 led to isolation of a crystalline
substenoe containing 65 per cent iodine.
relatively small a.mounts.

It proved to be toxic in

An average normal individual oen ingest

several gra.ins of inorganic iodine compound daily without any
perceptible physiological reaction whereas administration of 1/60
grain of thyroxin daily to the same individual produces characteristic symptoms of thyrotoxioosis.
Plummer and Boothby (149) found the body to contain approximately
7 mgms. of thyroxine which varies within narrow limits in a normal
individual.

A single injection of 10 mgms. of thyroxin into a

completely myxedematous patient results in a continuous increase in
metabolic rate until a maximum 1s reached on about the fourth day.
After this the rate slowly deolines until in 4 to 6 weeks it reaches
its previous subnonnal level.

It is estimated that a daily output

of 0.25 m.gm. of thyroxine is needed to maintain normal heat production.
Recently# Harrington (80) presented a convincing synthetic
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proof of the probeble course of events in the synthesis of thyroxine
in the thyroid gland.

The evidence points to diiodotyrosene as

being the natural precursor of thyroxin.

The process appears to

involve two steps, (a) iodization of tyrosene to form diiodotyrosene,
and (b) coupling of two molecules of diiodotyrosene to form
thyroxin.

The first step requires the presence of free iodine.

Since exogenous iodine reaches the gland in the form of iodide,
the system is believed to require a strong oxidizing agent to convert
the iodide to iodine.

That such an agent might be present in the

thyroid was indicated by Dempsey who demonstrated in the follicle
cells a peroxidase which tends to disappear from the cell under the
influence of thiourea.

1

1
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PATHOLOGY
Many clsssifications of goitere according to pathology,
etiology, clinical symptoms, or a combination of these have been
attempted but were found impractical in clinical medicine.

The

following classification was based upon Plummer's (120) conception
of the disease of the thyroid and has so far proved to be the most
satisfactory one.
( ~t)
(b)
(c)
(d)

Non toxic diffuse
Non toxic nodular
Toxic diffuse (Exophthalmic goiter, Grave's
disease, Basedow's disease)
Toxic nodular (Plummer's disease, toxic
adenoma)

In this study, only the toxic diffuse and toxic nodular goiter
will be considered.

Each of these, or their combination is associ-

ated with the signs and symptoms of thyrotoxioosis.
The pathological picture is that of extensive hyperplasia,
hyperemia, increased vasculRrity, and secreti~n of abnormal colloid
characterized by diminished eosinophilic reaction.
The gland in the diffuse toxic goiter is enlarged in variable
degrees.

Grossly, it appears reddish in color, finely grained, firm,

regular in outline, and suggestive of a beefy appearance.

Although

the enlargement is diffuse, it may be more marked on one side than
the other.
A

microscopic picture presents round, oval. or irregular follicles

lined with epithelium which ranges in size rrom cuboidal to tall
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columnar.

The follicles show numerous infoldings of epithelium and

contain smell amounts of feebly staining colloid.

The individual

columnar . cells contain granular appearing cytoplasm with nuclei
occupying a central position.
observed.

Mitotic figures may be frequently

This hyperplasia presents the sellle histological picture

wherever found.

(Fig. 5)

The degree of _toxicity is believed to be

determined by the functional activity of the tissue.

Fig. 5
Microscopic section from a diffuse toxic thyroid
showing follicles of various sizes lined _w ith columnar epithelium.
with papillary infoldings. x360

The hyperplasia is not limited to a toxio goiter alone, _but is
frequently observed in the thyroid of a new born, at puberty, during
pregnancy, end to a lesser degree during menstruation.
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In the latter

situations, the hyperplasia is said to be physiolog~cal.

These same

histological changes are observed in thyrotoxicosis, except, to a
greater degree.

(23,29 1 168)

A nodular toxic goiter is a focal encapsulated hyperplasia

within the parenchyma of the thyroid.

Single or multiple nodules

may be found, varying in size, consistency, and color.

Adenomas

are most apt to show hemorrhagic, fibrous, hyaline, calcarious,
granular, end cystic degenerative changes.

The hyperfunctioning

portion is limited to the area of encapsulation.

The follicles

have an identical picture with that found in diffuse toxic . goiter.

The thyroid outside these areas presents a normal histological
picture. (Fig. 6)

Fig. 6
Toxic adenoma at right showing follicles of various
sizes part of which a.re lined with columnar epithelium with papillary
infoldings much in evidenoe. Well defined capsule in the middle
with practically norm.al thyroid gland on the right. From Broders
and Parkhill.

36

Thyrotoxicosis is believed to affect nearly every organ and
tissue in the body either directly or indirectly.

The end-results

are characterized by varying degrees of pathology reported by
workers in this field of investigation.
NERVOUS SYSTEM

Study of the nervous system in thyrotoxicosis shows evidence
of changes in both the brain and sympathetic nervous system especially in those cases with a prolonged duration of symptoms.

Wilson

and coworkers (193,196) demonstrated definite histological changes
consisting of (a) fatty inf'iltration within the genglion cells,
(b) atrophy and reduction in the number of ganglion cells, and
(c) diffuse fibrosis of the entire ganglion.

These workers believed

the changes were due to either direct effect of the excessive
amounts of thyroid hormone leading to overfunction end then inevitable degeneration or secondary to degeneration of muscular and
glendular tissue.

The pathology was observed to be parallel to the

stage and intensity of symptoms.

Di8lllond succeeded in demonstrating

definite changes in the brain characterized by edema of the cerebral
parenchyma, degeneration of ganglion cells, and aseptic meningitis
in the pia arachnoid.

The etiological basis for these findings are

unknown.
HEhRT

Probe.bly no other organ has had so muoh attention directed to
,zl

it as the heart in thyrotoxicosis.
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That the thyroid overactivity
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\
may cause, or lead to cardiac disturbance has been long an accepted

fact.

Hrunilton found significant heart changes in about 35 per cent

of his series of cases.

A review of 306 cases in the University and

Clarkson Hospitals by Niehaus reveals 25.8 ~er cent of these to
have some form of cardiac disturbance.

A similar study ma.de on 409

consecutive thyrotoxic patients in Peter Bent Brigham Hospital (104)
from 1923 to 1941, shows 19 per cent to be associated with cardiac
disturbance.
Age may have an important bearing upon the frequency of cardiac
involvement.

Niehaus, Hamilton, and Huxthal found thyrooardiac

conditions most frequently in those approaching the age of 50 years.
Huxthal studied 500 thyrocardiac cases.

The average age of patients

who developed auricular fibrillation was 49 years~ while cardiac
decompensation was found to occur at an e.vere.ge age of 54 vee.rs.
Overwork due to increased metabolism was considered to be the sole
cause of heart failure.

Auricular fibrill~tion was regarded only

as a manifestation of thyrotoxicosis, and not in itself an evidence
of myocardial damage.

(87,97)

It was stated (87) that if thyro-

toxicosis leads to heart damage there should be more evidence of it
in the younger age group since the peak of the disease occurs in
that age group.

In the opinion of Lerman and Means, the so called "thyroid
heart" is seldom produced by thyrotoxicosis per se unless it is
superimposed upon a hypertensive, rheumatic, syphilitic, or arteriosclerotic heart.
There appee.rs to be no unenimity as t-:i the structural changes
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found in the thyrotoxic heart.

In an anal:rsi s of' 1., 244 consecutive

necropsies at the Mayo Clinic, (193) the most prominent histological

.

changes observed in the myocardium varied from mild to extreme
fatty degeneration.

The significance of the findings is questionable

since no control group was used •
Weller and associates found in 35 cases of uncomplicated thyrotoxicosis, patches of fibrosis in 80 per cent and cellular infiltration in 31 per cent, but they observed sim.ile.r changes in controls
in 52 per cent and 17 per cent respectively.

Other workers (152)
'

observed necrotic fibers in 5 out of 27 patients, but could not
account for any process which would produce the specific lesion.
Goodpasture and Wilson are of the opinion that thyroid intoxication predisposes the heart to agents that normally produce no
effect upon it.
The importance of cardiac involvement in thyroid disease is
emphasized by the higher rr.orte.lity following thyrcidectomy in the
ce_rdie.c th!:Jl in the uncomplicated groups. (95)

However, e_t the Peter

Bent Brigham Hospital (104) surgical mortality in 310 cases without
heart disease was 2.6 per cent, while in 99 cases ~~th cardiac
involvement there was no mortality.

LIVER
Hepatic damage is reported to be a frequent finding in thyrotoxioosis.

Weller observed marked parenchymatous changes character-

ized by simple and pigment atrophy, cloudy swelling, fatty infiltration, enlargement of portal canals, end fibrous overgrovrth in
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hepatic tissue removed from patients a.t necropsy.
aent of his 48 oa.ses had marked hepatitis.
less defined ohanges.

Fifty-four per

The remainder showed

The lesions are said to be severe enough to

account for the presence of jaundice (l '7) and bo produce disturbance
in hepatic function detectable by laboratory tests.

Chesky and

coworkers (34) using hippuric e.cid test demonstre.ted low excretion
of hippuric acid in nearly 50 per cent of patients with toxic diffuse
goiter while patients with toxic nodular goiter had 12 per cent
significent and 21 per cent moderate impairment.

Bartels reported

finding only 18 patients out of his series of 148 who responded
normally to this test.
No rele.tionship was found between the degree of pathology and
the size of the liver.

The majority were smaller than normal. (198)

Atrophy is reported (17) to be more pronounced among females than
among males, a.nd we.s observed to be more marked among the aged than
among the young.

This was found to be proportional to the severity

of the disease, but there was no correlation with the basal metabolic
rate.(200)

Although nearly all of the deaths reported were accompanied

by fulminating thyrotoxicosis, there was no uniformity in histological appearance of hepatic tis~~e, end it is difficult to attach
any specific significence to such chenges.

Sanger and Hun concluded after making glucose utilize.tion
studies that there was a failure of glucose storage as a result of
toxic chenges in the hepatic ti~sue.

Others (17) are of the opinion

that the pathology is rele.ted at lee.st in pa.rt to piissive congestion

.

seconde.ry to cardiac decamp ens a ti on.
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Baldridge and Peterson observed an enlarged spleen in 30 per
cent in one series of 144 thyrotoxic patients.

These findings were

associated exclusively -with toxic diffuse goiter.
diseases necessarily were ruled out.

Malaria end other

No explanation could be found

for this except that the spleen was a pa.rt of a genere1ized lymphoid
hyperplasia.

GASTRO-INTESTINAL
Thyrotoxic patients often com.plain of gastro-intestinal symptoms
but the underlying pathology is a matter of conjecture.

Berryhill

and Williams found 68 per cent of thyrotoxic patients with achlorhydria after histamine sti~~lation.

A majority of these returned

to normal within 6 months follo-vdng thyroidectomy.

Brown and

associates noted the incidence of achlorhydria to beoome more
frequent as the metabolic rate increased.

These investigators also

reported observing prominent gastric rugae~ increase in gastric
emptying; time, and an increase in both the tone and motility of the
entire gastro-intestinal tract.

However Sloan observed hyperchlor-

hydria and pyloric spasm as a prominent feature in thyrotoxioosis.
Diarrhea vmen present was said to be refractory, as a rule, to the
usual treatment effective in diarrhea.

The absence of signs of

intestinal disease were believed to point to nervous disturbance as
the sole ce.usati ve factor.
Schmidts demonstre.ted thyroxine to be much more toxic to
guinea pigs exposed to e. temperature of 32°0 and high humidity
than to those kept at 20°0.

Gastric ulcers were found frequently

41

in the former group.

Like~dse 1 the loss ot weir,ht was muoh greater

in the fonner group than in the latter.
RENAL
Accumulated evidence reveals the renal function as determined
by urea cleare.nce test to be unaffeoted by either the type of thyrotoxicosis, the duretion of disease, severity of disease, level of
basal metabolism, or the amount of weight loss.

(13,102)

BONE
Bone ehenges have been associated with hyperthyroidism for
many years. (15)

It was recognized in 1891 by von Recklinghausen

who reported a case of a young girl with a history of severe hyperthyroidism of a five year duration.
reported to resemble rotten wood.

The bones at necropsy were
Microscopic examination revealed

abunde,_nt resorption spaces in the cortex and numerous nests of
osteoolasts.
Osteoporosis has not attracted a great interest because patients
with thyrotoxicosis usually apply for treatment before marked changes
occur in the bones, end it usually is asymptomatic.
All bones have been observed to be involved.

The small e,nd

flat bones are reported to show changes first, later as the disease
progresses, the spine and long bones become involved. (13)

Means

and associates (129) believed the decaleification in thyrotoxicosis
to be a specific tyPe of inanition.

Cases were reported where

marked osteoporosis was complicated by kyphosis, flaring of the lower
ribs, and spontaneous fracture of the vertebra following a prolonged
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course of the disease. (129,150)
Negative calcium balance was suggested as the basis for
decalcification.

Calcium excretion in the urine and stools was

found to be increased, often as much as 231 per cent of the normal.
Normal individuals excrete on the average 4.2 mgms. of calcium per
Kg. of body weight per day, whereas in thyrotoxioosis, it was found
to be as high as 14 mgms. per Kg. of body weight per day.

In

patients who were under iodine treatment the excretion re.te was
normal.

Administration of desiccated thyr•:>id to normal persons

led to increased calcium elimination.

This depletion was believed

to be due either to the direct stimulating effect of the thyroid
hormone on the calcium deposits, parathyroid stimulation by the
sympathetic nervous system, or secondary to carbohydrate metabolism. (8)
The high rate of calcium excretion is not obvious in the blood
for essentially normal values were found both for calcium a:nd
phosphorus levels.
lv,.'11.JSCLES

Exophthalmos has been attributed in the past to overactivity
of certain smooth muscles of the orbit and to the increase in the
retro-orbital fat.

Naffziger studied muscles removed from exoph-

thalmic orbits and found them to be enlarged 3 to 8 times the normal
size.

Grossly these muscles presented a pale, edematous, half-

cooked appearance.

On microscopic examination round cell infiltra-

tion, loss of muscle architecture and an increase of fibrous tissue
with focal areas of hyalinization a:nd fragmentation were observed.
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He associated all the ocular changes with the varying degrees of
pathology in the extraocular muscles.
The same etiological factors which bring about the changes
in the ocular muscles mey be responsible for the generalized muscle
dystrophy which is sometimes associated with thyrotoxicosis. (9,173)
Means (128) calls attention to the freguency of these findings
when e. patient is carefully examined.

SKIN
The essential changes in the skin were reported by Youmans to
consist in alteration of texture, increase in moisture and temperature., abnormalities in pigmentation, and changes in quality and
quantity of hair.
The skin of a thyrotoxic patient has a tendency to be silky,
velvety., and with an unusual elasticity.

It usually fails to show

any evidence of weight loss due to preservation of the subcutaneous

tissues, and its close adherence to them.

These che.racteristics

were ascribed as due in part to elevated metabolism, and in part to
the increased P.eripheral blood flow which may also account for the
infrequency of decubital ulcers in thyrotoxicosis.
Pigmentation has e. tendency to be accentuated in patients with
thyrotoxioosis of long duration.

It was pointed out to be best

visualized on the exposed parts of the body suoh as the hends and
the face, and may simulate the pigmentation of Addison's disease
except that there is no pigmentation on the mucous membranes in
thyrotoxicosis.
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The growth of heir is believed to be associated with thyroid
function.

In thyrotoxicosis, the body hair is reported to be absent.

When present, the BJllount is small, with a tendency to be of a fine,
soft qua.li ty.
Experimental work has shown that feeding small amounts of thyroid
to rats resulted in an increased rate of hair growth, while large
amounts retarded not only the rate of hair growth but a.lso the quality
and

quantity of hair.

BLOOD
A review

(126) of 1 200 routine blood counts in consecutive
6

cases of thyrotoxicosis showed the red cell count to be within the
normal rAnge but the hemoglobin was slightly reduced.

Lymphocytosis

of 30 per cent and above was found in 60 per cent of the series.
Studies (111) on serum cholesterol indicate no definite
correlation between the cholesterol value and basal metabolic rate.
Although thyrotoxic conditions were found to have a tendency to
diminish the level of cholesterol.

The lowest values were found to

exist in the extremely toxic pati. ,.mts.
1

~.,ro1:.. the sta.ndpoint of

gravity of the disease, serum cholesterol appears to have a ~c~e
definite relationship.
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TREATMENT

TREATMENT

,I

I

SURGERY

rI

There is perhaps no other subject on which there exists a
greater differenoe of opinion than the tre~tment of thyrotoxicosis.
Lahey's (96) statement that "those who recommend measures other than
surgice.l e.re diminishing in number" carries an implication that

other forms of treatment are unsatisfactory.
exnresses

811

Hauser likewise

opinion that there is no such a thing as medical

management in thyrotoxicosis, and considers it unwise except in a
very few carefully selected mild cases.

The medical management,

he points out, is primarily iodine administration.

Those patients

who receive, it usually progress to severe forms of disease when
surgical risk becomes unfavorable.

However, he pleads for the

formation of "thyroid teams" consisting of an internist and a
surgeon to insure success in the treatment of a difficult case.
Others (142,150) would add to this team a radiologist, laryngologist,
psychiatrist, and anesthetist since thyrotoxicosis at times enters
as a complier.ting factor into every branch ~f medicine.
Surgery has been and still is considered the only means of
alleviating the effects of the disease and thereby restore the
patient to a stnte of economic efficiency i~ the shortest possible
time, (82) but even surgery has not been entirely successful in this
respect.

It is the feeling among clinicians that surgery is only a

symptomatic treatment, and assuredly not an ideal treatment, nor
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that it will be the ultimate treatment. (97)
The surgical aspect of the treatment consists of three phases,
(a) the preoperative preparation of the patient, (b) surgery, and
(c) postsurgical care.

It embodies two requisites, a production

of a partial remission and prevention of a further case of activity.
The former is neoesse,ry except in some early and mild cases, so that
the prevention of future activity may be more satisf'aotorily aohieved
by

thyroideotomy.

There have been no radical changes made in the

preoperative teohnio other than a more careful attention to essential
details in order to place the patient where all the requirements for
safe surgery have been met.
1.
2.
3.
4.
5.

These consist of:

A consistently lower pulse rate, preferably below 90.
An increase in weight, or at least a stationary
weight.
Lowered basal metabolic rate.
Lessened nervousness.
Good morale.

Comnlete bed rest is the prime requirement.

This is best

achieved in a hospital, and if possible in a private room.

Sedation

is essentie.l in the form of either barbitals. chloral hydrate, or
sodium bromide in quantities sufficient to reduce nervousness to the
minimum.
corrected.

Likewise all factors which tend to produce worry should be
A high vitamin, high calorie, high protein, high carbo-

hydrate dietary regime is recommended in an attempt to satisfy the
metabolic needs and provide for tissue building. (133 1 167)

In all

cases iodine is recommended in the form of Lugol's solution in doses
of 10 to 20 minims, three times per day depending upon the degree of
toxicity and severity of symptoms.

Iodine is claimed to be an

effective agent in producing a remission of symptoms of thyrotoxicosis,(45)
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although its mode of aotion on the hyperplastio thyroid is still
unknown.

(Fig. 7)

Fig. 7
Diffuse goiter showing effect of iodine administration.
The cells lining follicles are for the most part flat or low
ouboidal with some columnar. xlOO From Broders a:nd Parkhill.
Since Plummer (112) introduced Lugol's solution for the treatment of toxic diffuse goiter, iodine has been a routine agent in
preoperative management of patients.

Following its use, the operative

mortality in toxic goiter was reduoed almost 25 per cent at the Mayo
Clinic (119) and resulted in an increase in operability.

The

X,

patients who fonne~ly were considered too ill for surgery were
rendered safe by iodine in 10 to 21 dey-s.

Even with its use there

still remains a group in which a surgical procedure is

a serious

risk.

This group either does not respond to iodine therapy as a result of
some complicating factor, or has developed iodine tolerance following

prolonged iodine therapy withou~ properly surveying the onset of the
maximum. benefit. (89)

Lahey (90) would like to impress upon the

femily physician the importence of iodin~ therapy in relation to
goiter surgery.

He believes that muoh of iodine fastness results

from indiscriminate use of it in the treatment of' this disease.
According to Crile, (45) there is no such thing as iodine fastness or iodine escape.

He is of the opinion that iodine will exert

a definite effect on the secretory meohenism of the thyroid so long
as it is being administered.

The phenomenon of iodine fastness is

believed not to be due to iodine failing to exert its depressing
effect, but rather to en exacerbation of disease in spite of iodine.
The disease would be much more serious without iodine or had it been
withdra'Wll, although, he goes on to say that the progress of the
disease would not be altered or oured by its continued use.
Choosing of the time for operation depends largely upon the
success of the preoperative management of the case.
patient is improving the operation is delayed.

As long as the

The general condi-

tion of the patient, pulse rate., weight., bRSa.l meta.belie rate end
the degree of nervousness are taken into consideration.

Insistence

is me.de on a careful exa.mination of' the patient before attempting
any surgical interference.

Many of the operative failures a.re directly

attributed to faulty selection of patients suitable for operation as
a result of inaccurate appreisal of symptomatology, provocative
pathology, and certain complications. (133 1 187)
Surgery is said to be contraindicated in:
1.

Those patients who have not had the benefit of careful
scientific medical care without sufficient time to
accomplish full results.

49

2.

Those "V'vi.th nephritis, malignant hypertension, arteriosclerosis, bacterial endocarditis, rheumatic inf'ectiona
or upper respiratory infections.

3.

Those whose basel metabolic rates preoperatively are
-15 or below.

4.

Those with decompensated hearts which do not respond
to digitalis. (187)

However, Steeves says that a purely "thyroid heart" must be
very bad to be a contre.indicetion for thyroid surgery, in fact "the
thyroid heart may be in too bad a shape not to operate".
The type of operation should be based on the type of case at
hand, and the surgeon's experience.

Thyrotoxicosis is considered

as an uncertain disease capable of producing unexpected fatalities.
If in doubt, it is believed that a surgeon should perfonn a ligation
and then a hemithyroidectomy. (167)
Ligation frequently leads to a marked improvement in the
patient's symptoms.

Grodinsky claims that the beneficial effects

of the preliminary ligation of one or more poles a.re due prob~bly
more to interruptions of nerve impulses to the gland then to the
actual reduction of blood supply since there is a rich collateral
circulation.

It will be recalled that the nerve supply of the thyroid

is derived from the sympathetic plexus around the carotid and
subclavian arteries, the branches of which reach the thyroid along
the arteries supplying it.
Sealy and_Kernoble recommend a two stage procedure with 10 to
12 days between stages~ in all poor risk patients.

In their hands,

this has proved to be the most satisfacto~r method in reducing;
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mortality and severity of postoperative reactions.

The basal meta-

bolic rate was claimed to be much lower at the end of 10 days
following the first stage procedure than at the end of 6 weeks, and
the patients seemed to do much better.

Surgical wound infections

did not increase as a result of the shorter between stage interval.
The majority of deaths following thyroidectomy are attributed
to postoperative thyroid reactions or the so called thyroid crisis
which is simply an exa.cerbe.tion of all symptoms of thyrotoxioosis
to the nth degree.
is known.

Neither its etiology, mechanism, or pathology

Some believe it to be due to a disturbance of body

chemistry, or possibly to an excessive release of adrenaline into
the system e.s a result of fright or some other predisposing factor.
(109,153)

It is characterized by a rapidly progressive course,

vomiting, sweating, rapid pulse, hyperpyrexia, irrationalism, and
finally circulatory collapse.
Continued administration of iodine in preoperative doses,
intravenous glucose, fluids# and adequate sedation for the first
two or three po stop ere.ti ve days was suggested as effective means
in averting thyroid orisis. (45,109)

A more careful choice of the

anesthetic agent with particular emphasis on avoiding ether, is also
stressed as being an important factor in reducing the incidence of
this complication.

(82 1 96)

Recent limited experimental work with thiouracil as a substitute
for iodine in the preoperative ca.re indicates the drug to be superior
to iodine in producing remission of symptoms end eliminating the
incidence of postopers.tive crisis. (12,188)
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RADIATION

There is a consensus of opinion ronong radiologists (11,142,172,175)
that irradiation is indicated in all cases of hyperthyroidism with
an exception of those suffering from crisis or pressure symptoms.
The end results e.re claimed to be approximately equal to surgery.
The loss of life is negligible from this form of tee.tment, and at
the same time the pe.tient remains eJnbulatory with a minimwn of
economic loss.
Both the surgeon and the ri::.diologi st aim at the reduction of
the hyperplastic oversecreting tissue.

The surgeon is s!:l.id to have

no v,re.y of judging as to vme.t constitutes the correct amount to be
removed so as to give relief from the· symptoms, and at the seJne time
leave enough tissue for the reouirements of life.

The radiologist

on the other hand claims to be able to reduce the cellule.r activity
g;rpdur,lly with cerefully controlled doses of roentgen rays.

By

carefully observing the symptoms and basal metabolic rate, he need
not exceed the dosage necessary to bring about a. norm.al condition.
Certain advantages are cldmed for irradiation over other forms
of treatment.
1.

Irradiation eliminates fear of operation hence the
patient is likely to present herself for treatment
much earlier in the course cf the disease.

2.

Earlier treatment means that the patient ce.n be
treated while ambulatory and without loss of time
from occupation.

3.

Earlier treatment elimine.tes the possibility of
cardiac damage.
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4.

Treatment is associated with no pain, shock, or
inconvenience if begun reasonably early.

5.

Patients with advanced disease or with some serious
complication may be treated without shock in their
own rooms if radium is used.

6.

Risks of mortality, scars, and keloids are eliminated
in competent hands.

7.

The end results equal surgery.

Occasionally objections are said to be raised to this form
of therapy on the basis that:
1.

Patients respond too slowly to irradiatione

Improvement

is cl~med to be noted by the end of the first month and definite
improvement by the end of two months which is approximately equal to
the time spent in preoperative and postoperative care and convalescence.
(142,172)
2.

Serious burns may result.

These occurred during the earlier

years, but with the present technic, this hazard is entirely
eliminated. (142)
3.

Telangiectasis and atrophy of skin may occur.

admitted to be a danger which needs consideration.

This is

It was found in

3 per cent of the earlier treated oases, however, the latest methods
have eliminated it by rigidly controlled doses. (11,142)
4.

Irre.die.tion increases adhesions so that the surgical

treatment is rendered dif:'icul t.
proved.

This is said to ha.ve never been

Adhesions a.re reported found as often in non-irradiated

as in irradiated cases. (142)
5.

The complication of myxedema is greater from this form of

treatment than following surgery.

This likewise is said to have
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been entirely elimine.ted
tissue.

•

by

gradual reduction of hyperfunctioning

There a.re elso indicetions that normal thyroid and para-

thyroid tissue is resistant to roentgen rays. (142,180)
6.

Carcinoma may develop in a toxic nodular goiter following

irradiation.

The condition is believed to be very rare.

found only one out of 501 cases.

Pfahler

Besides ca.rc.inoma of the thyroid

is claimed to be sensitive to roentgen rays which may partially
account for its infrequency.
7.

Irradiation do es not ]'.)roduce last1.ng results.

Exacerbation

of symptoms are reported occasionally and a.re believed to result
from some predisposing factor such as fooa.1 infection in tonsils,
sinuses, or elsewhere.

Roentgenologists insist on the removal of

foci of infection before attempting treatment.

Failure to do so is

claimed to lead to unsatisfactory results. (11,142,175)
Pfahler advises against the use of iodine prior to irradiation
therapy.

In his experience the results were not as good when iodine

was employed.

He believes the rays to be more effective when the

thyroid cells a.re in excited state.
not of the same opinion.

However, Sa.ley and Stone are

They find that it may be useful in the more

toxic patients for a varie.ble length of time.

'fheir series of cases

included 22 patients who received Lugol's solution and obtained
equally as go0d response to roentgen therapy.
The clinical course during irradiation is said to be uneventful.
Occasionally patients present s;ymptoms of increased toxicity for a.
few days follo~~ng the first treatment but this rapidly subsides.
Likewise., a. slight increase in the size of the gait.er ma.y follow the
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initial treatment.

This is of no consequence except in those who

oresent pressure symptoms prior to treatment.
indice.tes these latter to be surgiee.l problems.

Unanimity of opinion
Gastro-intestinal

disturbances when present were usually the first to disa.puear early
in the course of treatment.

This is reported to be followed by

decreased nervousness, sweating, .md appetite.

Eye signs were the

last symptoms to disappear. (11,142)
The following a.re the sunnnarized reports on irradiation therapy
in thyrotoxicosis from~some of the larger clinics and present e. cross
section of results obtained from this form of treatment.
Bingham. and Richards in 1920 repJrted over 300 cases to shov1 the
method to be scientific and logical in modifying the course of the
disease.

They reported 50.3 per cent cures as indice.ted by dis-

appearance of symptoms.

A smaller group of 11.3 per cent were said

to be im-proved.
Rowe theorized in 1924 that the toxic goiter was a good field
for roentgen ray therapy.

All 50 of his oases including 10 who had

surgery previously, benefited as indicated by weight gain, lowering
of the basal metabolic rate, and decrease in nervousness.

None

required surgery.
Christie believed the evidence at hand was sufficient to
warrant this form of thera-py.

He claimed the results to be invariably

better than those following surgery.

Four of his oases were entirely

relieved of all symptoms.
Sanger reported fifty cases treated by x-ray, 82 per cent of
whom were entirely free of symptoms after a year or more of
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observation.

Six per cent were said to have been moderately im-

proved while 8 per cent required surgery.
Barclay declared that x-ray should be employed in all oases of
toxic goiter before resorting to surgery.

Out of 300 cases treated

by roentgen rays, 63.3 per cent were reported cured, 16 per cent
moderately improved, while 5.3 per cent showed no improvement.
Four patients (l.3 per cent) in this series died of hyperthyroidism.
Grover end associates treated 305 patients with all grades 0£
severity of the disease and with en average duration of symptoms
of 2+ years.

Twenty-six of these patients (8.5 per cent) had previous

thyroideotomies.

Of this group, 271 (88.85 per cent) were claimed

to be cured, 26 (8 per cent) improved, and 8 (2.7 per cent) unimproved.
Two hundred fifty of these patients were followed for periods from
1 to 11 years while the remainder were observed for less than a
year.

Hypothyroidism was reported in 1.3 per cent of the cases but

was adequately controlled with desiccated thyroid.
Stevens enthusiastically recommends roentgen ray treatment for
toxic diffuse goiter.
goiter.

His report represented 270 oases of toxic

The ages ranged from 12 to 74 years.

Two hundred forty-three

(90 per cent) were declared cured while 27 patients were definitely
improved.

All the patients were followed for a period longer than

a year.

Pfahler reported 65 per cent of his patients to be cured by
irradie.tion therapy and 20 to 25 per cent to be decidedly benef'i ted.
He recommends this form of treatment in all cases of hyperthyroidism
except for those with thyroid crisis end pressure symptoms.
Soley end Stone selected 43 oases of unquestioned thyrotoxicosis
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for treatment with roentgen rays at the University of California.
Hospital.
goiters.

Of these, 31 had toxic diffuse and 12 toxic nodular
Twenty-five patients (67.6 per cent) were entirely freed

of all symptoms, 8 patients (21.6 per cent) were markedly improved 6
and two died during the course of treatment from congestive heart

failure which was present for 2 and 4 years prior to treatment.
Four patients had to be operated upon subsequently because of
failure of x-rays to control the course of the disease.
Some radiologists (175) and surgeons (82) recommend this form
of therapy in all poor surgical risks in whom the treatment is a
life saving procedure.
The following case history of a patient (Figs. 8 & 9) who was
recently treated by x-re:ys for severe thyrotoxicosis at the University
of Nebraska Hospital indicates what may be accomplished for those
who are poor surgical risks.
Patient H.
July 15, 1944.

c.

#82150, 33 year old housewife admitted on

Treated with Lugol 1 s solution for several months

prior to admission.
Present Illness

-·

1.

2.

3.

4.
5.
6.

-

Nervous since age of 16 following appendectomy,
markedly increased 1 year.
Loss of 25 pounds weight in 2 years in spite of
hearty appetite.
Goiter since Jan. 1, 1944, pr,")gressively increasing in size.
Intolerance to heat.
Tachycardia and dyspnea.
Edema of ankles and legs, 3 weeks duratione
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Phy_sioal Findin~
1.
2.
3.
4.
5.

6.
7.

Nervous and e.pprehensi ve
Skin hot and moist
Thyroid symmetrically enlarged
Veins over neok prominent
Heart enlarged to left of anterior axillary line
with a blowing systolic murmur heard over the
-whole precordiwn
Pulse 102, B. P. 172/88, B. M. R. +76
Liver and spleen enlarged

Treatment
July 15 - 31
Lugol's solution 6 gtts. t.i.d. end sedation.
improvement.

No

July 31 - Sept. 8
Tiouracil, doses 0.2 to o.s grams per day. No
improvement. Surgery declared patient a poor risk.
Sept. 8 - Oct. 3
Lugol's solution 6 gtts. t.i.d.

No improvement.

Oot. 3
Consultation with radiology. Advised 75 roentgen
units anteriorly elld posteriorly onoe daily for one
week, 3 times the second week., 2 times the third
week, end once on the fourth week. No improvement
expected for about 10 weeks.
Oct. 3 - Nov. 1
888 roentgen units enteriorly and 888 roentgen units
posteriorly each right and le.ft.
Nov. 7
Patient dismissed, unimproved. Advised to go home
and lead a life of leisure. To return in 5 weeks.

Deo. 16
Patient returned.

Some improvement.
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Dec. 16 - Jan!

a,

1945

835 roentgen units direct, anteriorly.
Jan. 30 - Feb. 12
65i roentgen units each right and left, posterior
tangent.

Feb. 1
Patient much improved.

B. M. R. +33

Fig. 8
Left. Patient with a toxic goiter before x-ray
therapy. (Oct. 1944)
Fig. 9
Right. Same patient 6 weeks following the first
course of x-rey therapy. (Deo. 1944) Goiter markedly deorea~~d ~ ~
in size.
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MEDICAL MP~1AGEMENT
The literature on the subject or medical treatment of thyrotoxicosis is practically nonexistent. 'Only recently some clinical
men began to realize that professional team ~~rk is necessary if
good results are to be obtained, but even at that, the role of the
internist is limited to preoperative preparation or the patient,
postoperative management, and in some cases to treatment of complications associated with the disease. (95,176)
The statement (133) that medical treatment of hyperthyroidism
has dragged a great many Patients into the hands of unscientific
and unreasonable forms of treatment, leaves e.n impression that
medical management in the past had little if anything to offer for
assuaging its symptoms.

Bram (25) who has always steadfastly de-

fended the medical management of thyrotoxicosis says that "it is a
reproach to the internist that the surgeon should have been compelled to operate so frequently in Grave's syndrome.

When such cases

properly treated could respond satisfactorily to conservative
measures~.
Its correotion, he points out. requires attention to the human
being as a. whole, rather then to a lump on the neck.

He does not

include toxic adenoma in this category since he classifies it a.s a
neoplastic condition assuming a toxic role and being entirely a.
surgical entity.

He believes the diffuse toxic goiter to be a

disturbene of the entire being and a:mena.ble to conservative treatment.

He reported 3,000 patients with diffuse toxic goiter who

received medical treatment end who were followed after recovery
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during the past 25 yea.rs.

The follow up of these patients is

summarized in Table I below.
. Tl.BLE I

Follow up of 300 cases treated medically by Bram
Period of follow up

Number of patients

Over 5 years

2,490 (83%)

Over 10 years

390

(13%)

Over 15 years

90 (3~)

20 to 25 years

30

(1%)

Eighty-eight per cent of this group of patients were reported
to be enjoying normal health.

Table II shows the distribution of

patients after medical treatment.
TABLE II
End-results of 3,000 cases of Grave's disease
treated medically and followed up 5 to 25 years.

2,640 (88%)

Normal heal th
Mild exophthalmos (otherwise normal)

120

(4%)

Heart enlargement (mainly objective)

105

(3.5%)

:t/.ild clinical hypothyroidism

45

(1.5%)

Mild exophthalmos and heart enlargement

36

(1.2%)

Mild exophthe.lmos, heart enlargement,
and hypothyroidism

54

(1.8%)

A majority of the patients with a residuum ere reported to have

been either thyroideotomized or exposed to extensive radiation
previous to coming under medical management.
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These presented some

difficulties in handling but the mild sequelae did not interfere
materially with life.
The guiding principles of this management consisted principally
of (a) diet, (b) drugs, and (c) psychotherapy.
The diet included a liberal supply of carbohydrates, butter,
end other dairy products. fruits, and vegetables.

Tea, coffee,

condiments, smoking, and alcoholic drinks were forbidden.

The a.mount

of food during the early part of the treatment often amounted to
twice the amount ordinarily required.

ThiE was gradually tapered

off as improvement took place in the patient's condition.

Insulin

in small doses was used effectively in some cases to combat undernourishment and ca.rbohydra.te intolerance.
The drugs which he found useful included quinine, although
95 per cent of the patients were ss.id to be relatively immune to
the drug, iodine in some cases, sedatives for relief of insomnia,
and prostigmin bromide.
Bram's (26) la.test experimental v.ork with the latter drug is
worthy of note.

The use of prostigmine bromide is based on the

evidence that the autonomic nervous system is involved in the
production of the syndrome in Grave's disease.

The immediate cause

of tachycardia was said to be due to dominating sympathicotonia
over which the checking influence of the vagus is inadequate.

He

states ths.t any measure which will alleviate sympathicotonia. will
result in improvement of the symptoms.

The drug was shown to exert

a. favorable influence not only upon the heart. but on the exophthalmos,
the thyroid, and go.stro-intestinal tract as well.
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The drug was

administered in doses of 7½ to 15 mgms. three times per day for
periods averaging 10 weeks.
The reactions of a patient ~~th thyrotoxicosis led him to believe
that it is a typical syndrome of psychosomatic disturbance., and that
psychotherepy wi:ts not only useful but timely.

It is this phase of

treatment that deme.nds considerable a.mounts of the internist's
time in order to employ the necessary tact end paternal spirit to
eradicate maladjustments thet were present.

Assistance of a minister,

prie~t, or rabbi was found useful in this p~~se of treatment.
The course of clinical events was variable.

Tachycardia and

tremor were said to be the first noticeable symptoms to improve ins
few weeks to a few months.

This was followed by weight gain, heart

improvement and involution of the goiter.

Exophthalmos was reported.

to be the last symptom to improve, but this wa.s variable.
Mo.st of the pe.tients were allowed to continue with their work
but were counseled to adopt an early-to-bed routine, curtailment of
both bodily and mental strains., e.nd to follow closely the therapeutic
suggestions.

Those with the severe forms of disease were hospitali~ed

until definite improvement was observed.
Probably the most serious challenge to the hitherto undisputed
sway of surgery in the treatment of thyrotoxicosis is offered in the
recently discovered drugs which are seid to exert a profound influence
on the activity of the thyroid gland.
Workers in the field of research have observed for several years
that laboratory animals when kept on a certain diet almost invariably
developed goiters.

Chesney and associates observed a remarkably
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great enlargement of the thyroids of rabbits which had been fed a
cabbage diet for variable periods of time.

The thyroids of some of

these animals weighed over 40 grams whereas the upper limits in a
control animal never exceeded 1.73 grams.

Microscopic studies of

the hypertrophied glands revealed a greatly reduced colloid content,
columnar epithelium end small follicles with poorly de.fined lumina
which were filled with invaginating epithelial cells.

The basal

metabolic rate in these anime.ls was observed to be subnormal.
Administration of iodine increased the basal metabolic rates and
produced involution of the glands, but in most instances the animals
died.
This work was confirmed by Marine and associates. (117)

Later

they discovered that members of the Brassica group, as well as,
cabbage had the property of producing hypertrophy of the thyroid
glands of rabbits.

Investigation of composition of these plants led

to a belief that the goiteroua condition was due to cyanide compounds
that were found in all of them.
Griesbaok and associates found no activation of the thyroid in
a completely hypophysectomized rat.

Hyperplasia preViously produoed

regressed rapidly after hypophysectomy in soite of continuous administration of the active prinoiple.

They concluded that the effect

of the active principle required the mediation of thyrotropic hormone.
Later, Kennedy while studying goitrogenous properties of Brassica
seeds suggested that the active materia.l was a derivative of urea.
The recent discoveries of Astwood end associates (7) and
MacKenzies and MoCollom pointed to oerttln drugs as having en
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inhibitory effect on the function of endocrine glands.

The latter

while investigating the toxicity and effect of sulfanilylguanidine
as an intestinal disinfectant in rats observed hyperplasia of the
thyroid and a lowering of the basal metabolic rate after the drug
was edmini stered for e. period of time.

This hyperplasia was not

influenced by iodine but was abolished by thyroxin and desiccated
thyroid.
MacKenzies produced goiters in rats by series of sulfonelllides
and thioureas with identical results as w:_ere observed formerly.
The latter drug was found to be 8 times as effective as the same
dietary level of sulfa~uanidine.

They observed that the hypophysis

was essential to the production of thyroid hyperplasia.

Treatment

of hypophysectomized animels with these drugs failed to produce effect
on the thyroid gland which was histologically indistinguishable
from glands in untreated controls.

They concluded that these drugs

probably exert a depressi~g influenee primarily on the functional
activity of the thyroid,

hence the hyperplasia was a reflection of

increased pituitary compensation resulting from depression of thyroid
function.
Astwood et al. (7) repeated the former experiments using 147
rats placed on a 2 per cent sulfaguanidine diet for 1 to 153 days.
Grossly, the thyroids were found enlarged and reddened suggesting
increased vascularity.

Histological study confirmed the gross

observation of vescularity and hyperplasia, the degree of which
varied with the total dose of the drug.

The first change noted was

the increase in the height of acinar cells 1 followed closely by a
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loss of colloid and increased encroachment of papillary projections
into the lununa.

Iodine had no effect in ~reventing these changes

but they observed that hypophysectomized animals failed to show
eny enlargement of the thyroid gland.

They found the glandular

hypertrophy quickly regressing to a normal condition after withdrawal
of the drug.

They also showed that sulfa~a.nidine offered no pro-

tection against the lethal effect of desiccated thyroid or against
its oalorigenic action.
In spite of the marked hyperplasia of the thyroid in the
treated animals, these began to show subnormal growth, development,
and other signs of hypothyroidism.

This suggested that the drug

either exerted an action which inhibited the normal effect of the
thyroid gland hormone, or in some way interfered with the production
of the thyroid hormone.

In either case it was thought the goiter

would be a result of compensating hyperplasia which could not make
up for the hormone deficit induced by the drug.
Later Astwood (4) extended his study to 106 chemical compounds
to deter,d.ne their effectiveness in inhibiting the function of the
thyroid ~lend in young rats.

He administered these drugs in food and

water for a period of 10 days.

The degree of thyroid hyperplasia

by gross and microscopic examination provided an estimate of their

effectiveness.

Thiourea. derivatives and certain deri va.ti ves of

aniline were found to be the most effective but the latter were much
more toxic the.n the former.

Thiouracil was found to be the most

active substance of the thiourea derivatives.

Thiourea was less

toxic than thiouracil but imparted a peculiar odor to the breath.
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. Astwood (5) treated 3 thyrotoxic patients with thiouracil and
found it to be a.otive in producing remission of symptoms., raised the
serum cholesterol to its normal level., and lowered the basal metabolic rate.

When the drug was used for only e. month., e. relapse

followed its disoontinua.noe.

One of the pt:1.tients while receiving

2 grams of thiouracil daily developed a.gra.nulocytosis.

The drug

was tried on several normal persons but these experienced no drop
in the basal metabolic rate.
Thiouree. is a sulfur analogue of urea and has the following
formulas

H2N-OS-NH2•

2 - Thiouracil is a heterocyclic derivative

of thiourea and has the following formula:
H-N-0-==0
I

I

S= 0
C - H
I
U
H- N-C-H

It is a white, crystalline powder which is readily soluble in
an alkaline solution, slightly soluble in water., and insoluble in
ether, ethyl alcohol, s.nd acids.
or in the powder form.

It is relatively stable in solutions

It has no odor but is bitter to taste.

The exact mode of thiouracil e.ction is not known.

Earlier

experiments (7,124,125) ~uggested that the drug depressed the
functional activity of the thyroid ~land and thus decreased the basal
mete.belie rete.

The thyroid hyperplasia was explained on the be.sis

of incre&sed pituitary activity resulting from this depression.
Administration of thiourea. to normal rats by Astwood and e.ssocie.tes (7)
and later by Hughes (86) produced retardation of growth and development.
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Hughes demonstrated a oondi tion identical to cret;nism prod!J.~~d 1>Y
thyroideotomy immediately after birth, by
from the fir~t day of life. (Fig. 10)
to maturity 1 ed to irreversible oha.ng.es

administering thiouraoil

The treatment when continued
~

that when the drug wa.s

withdrawn no improvement resulted. (Fig. 11)

Fig. 10 (Upper) Thiouracil treated male and normal male litter
mate oontrol. (Age 10 weeks)
Fig. 11
From Hughes.

(Lower)

Sallle animals as in figure 10.

(Age 26 weeks)

Lea.them fed thiourea to rats for a period of 20 to 22 days and
observed a rise in the total plasma protein oonoentration whioh is
similar to a picture observed after thyroideotomy.

A mild anemia

and. or 1 euoopenia was found in some cases.
Keating and associat es applied the principle of radioactive
iodine to the study of action of thiouraoil on ohick thyroids.

Changes

in the thyroid following administration of thiouraoil were found .to
be identical to those which follow a daily injection of the thyrotropic
68

hormone.

Hypertrophy developed in a similar manner.

However, the

thiouracil developed goiters showed a greatly diminished capacity
li

to collect the radioactive iodine as compared with normal controls

,i~

and thyrotropic hormone developed thyroids.

'Ill•

About these.me time

Larson et al. succeeded in showing that thiouracil can reduce

with

equa.l facility the collection of radioaoti ve iodine by the normal

,;I,

~

I

thyroids as well as by the thyroids made goitrous by injection of
thyrotropic hormone.
From these observations, it seems probable that the primary
action of thiouracil is either by inhibiting the capacity of the
thyroid to collect iodine, or by suppressing the synthesis of iodine
compounds in the thyroid.
The latter theory is supported by Dempsey who demonstrated a
peroxidase in the thyroid cell which tends to disappear from the cell
when thiourea is administered.

The alternative hypothesis was

suggested by Astwood and Bissell who demonstrated that thiouracil
can act in vitro as a reducing agent converting iodine to iodide and
preventing oxidation of iodide to iodine, a change which is necessary
for formation of diiodotyrosene.
Williams and Bissel found thiouracil bo be rapidly absorbed
from the gastro-intestinal traot and rapidly excreted from the body.
When

o. 2

gram thiouracil was given to a normal person and blood

samples ta.ken at 15 minute intervals, the highest blood level,
2.3 mgms. was found 15 minutes after administration of the drug.
This fell rapidly until at 8 hours only 0.3 mgm. per cent was present.
However, the drug did not disappear entirely until the third day.
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When 0.2 gram was administered at four hour intervals, it required

about 24 hours to reach a more or less oonstant rate of excretion
(about 300 mgms. per day) in the urine and a maintenance of e.
constant blood level of a.bout 3 :mgms. per cent.

Most of the drug

in the blood stream was round to exist in the cellular elements.
The concentration in the white cells was many times of that in the
red cells although the total concentration was greater in the red
cells.
The distribution of thiouracil in the tissues was studied from
two patients who died from oerebral hemorrhage and bronchopneumonia
and each of whom received a total of l to 3.6 grams of the drug.
Most of the tissues including the thyroid contained from 1 to 3
mgm. per cent (fe.t free, dry weight).

The concentration in the

adrenals, bone marrow, and in the pituitary was somewhat greater
than this.

All stool specimens were free of the drug.

Since pregna.noy may be complicated by thyrotoxicosis, Goldsmith
and associates studied the effect of thiourea treatment on the offspring.

The experimental work with re.ts shows that the young delivered

of mothers fed on a

o.5

per cent thiouree. diet were retarded in

growth and had hyperplasia of the thyroid glands.

These effects,

however, were transient in nature, disappearing as soon as the drug
was withdrawn.

The mortality was no higher among the drug treated

than among the normal controls.

Thiourea was believed to be tra.ns-

mitted through the food~ through the placenta, or through the milk.

~
11

1:

i

I
,,

These workers also observed that the young rats placed on a

I,,

i'

thiourea diet over prolonged periods of time failed to produce
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offspring as long as the diet was continued.

A return to a normal

diet we.s marked by normal growth and physiological activity.
William end Bissell treated 9 unselected cases of thyrotoxioosis
with thiouracil.

In each case the toxic manifestations disappeared

and the basal metabolic re.tes declined to normal levels.

In four of

these patients, they studied the blood iodine levels and found a fall
of protein bound iodine to low nonnal or subnormal levels.

Three

patients showed a slight enlargement of the glend during the first
two weeks.

Eventually all the glands became softer and smaller.

In one case the thyroid gle.nd beoeme softer end smaller in association with treatment with desio.cated thyroid.

This method of treat-

ment was claimed to have a good rationale because it tends to inhibit the excessive production of thyrotropic hormone, thus preventing
thyroid hyperplasia and may control malignant exophthalmos.

Thiouracil

was administered in doses of 1.2 grams per day in divided doses until
the be.sal metabolic rate began to deoline.
to 0.6 too.a gram

The drug was then reduced

per dey in divided doses until the basal meta-

bolic rate declined to normal or near normal levels at which time
the dose was reduced to 0.2 grem

per day for as long as needed.

No

toxio reactions were reported.
Himsworth administered thiourea to 6 patients with thyrotoxioosis
with striking results.

No toxic reactions were observed in this

group.
Rawson and associates treated 19 patients with thiouracil and
reported lowering of basal metabolic rates which were associated
with alleviation of all symptoms of thyrotoxicosis.
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Some of the
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pe.tients showed hyperplasia of the thyroid glands.

Those who received

iodine prior to thiouracil therapy made a much slower response to
the drug.
Gabrilove and Kert reported 9 pe.ti ents treated with thiouracil
in doses of one gra.m per de:y.
untoward effects.

Three of these pa.tients developed

In two cases this was characterized by pyrexia

up to 105° F. and diffuse erythematous me~ulope.pular eruption all
of which subsided within 24 hours after discontinuance of thiouracil.
The third patient had received iodine for f'our months prior to
thiouracil therapy.

After being on one gram of thiouracil for 16

days, she developed marked leukopenia.
Welshman tried thiouracil on two oases of thyrotoxicosis.

In

both, the total white counts fell to about 2200 per omm. with a
depression of polym.orphonuclear cells.

In each case, the white blood

count rose to 10#000 per cmm. five days after discontinuance of the
drug.

The dosages were not stated.
Friedman likewise reported two patients treated with thiouracil

both of whom showed a depression of white blood counts to 2000 per
cnnn. following a short course of therapy.

The patients were sub-

mitted to surgery and the glands showed features of hyperthyroidism
with signs of involution characterized by cuboidal lining epithelial
cells and deep staining colloid.

The dosage of thiouracil was not

reported.
Sloan and Shorr subjected a number of patients to a detailed
metabolic study while under treatment for thyrotoxioosis with
thiouracil in doses of

o.a

gram daily.
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Observations were made on
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the inf'luence of thiouracil on the disturbance in cree.tin. crea.tinine,
calcium, phosphorus, eit.d nitrogen metabolism as well e.s on other
indices of thyroid activity.

The findings were comparable to results

following a successful subtotal thyroideotomy.

One patient of the

'i

series developed a mild jaundice with en ioteric indix of 27 after
20 days on thiouracil,

o.s

gram daily.

,:

This promptly subsided

!'

after withdrawal of the drug.

r

!j

Bartels treated 11 severely toxic pe.tients preopere.tively with
thiouracil.

I

Improvement was observed within 7 to 10 days after

beginning of the treatment.

The patients showed a gain in weight

and decrease in appetite, subsidence of nervousness, diminished
sweating, end a decrease in pulse end basal metabolic rates.
jective improvement preceded the objective improvement.
in the size of the glend was observed.

J

!

Sub-

~

No chenge

The preoperative use of

thiouracil in severe hyperthyroidism was claimed to have reduced
the total time of treatment, reduced the hospital stay, and limited
the surgical procedure to a subtotal thyroidectomy.

No toxic

I
I
!

reactions were observed.
Willie.ms and Clute have used thiouracil in the treatment of
72 patients with thyrotoxioosis including ~ontinuation of treatment
in the nine oases reported by Williams and Bissel.

Of these, 46

were treated for periods ranging from over 2 months to over 6 months,
while 24 were trented for less than 2 months.
not hospi tFli zed for over one day.
from 3 weeks to 22 years.

Mo st of these were

The duration of symptoms varied

Subtotal thyroidectomies were performed

previously in thirteen of the patients, one of these had two
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operations and one three operations.
Potassium iodide wa.s te.ken to within e. month by 13 patients,
e.11 of whom except 3 discontinued iodide before starting thiouraoil

therapy.

Three patients received iodide in conjunction with

thiouracil.

Two of these reacted to thiouracil about these.me e.s

they would heve been expected to react without previous iodide
therapy~
Many patients claimed a me.rked improvement within 24 to 48

hours after first taking thlo..,~racil.

Some discontinueo. th~ :lrug

a.ft er e. short c0urse a:..-id 0ontinued to be fr-ee of sy._<Uptom~ ·.hl le

othc~s expari0L~ed r~ld r6nissions and were put back on small doses
of the dr1..1g.

T'he basal ::r.ctabolic rate decreased more rapidly in

severe cases than in the others.

In essentially all of the patients

the basal metabolic rate remained normal during the course of treatment.
An increase in the size of the thyroid gland was observed in

11 patients during the first few weeks of treatment with thiouracil.

In two patients the gland was distinctly larger after two months of'

tree.tment, and in 8 others no change we.s observed at the end of 6
weeks.

Desiccated thyroid was given to 9 patients in doses of 0.6

to 1.5 gre.ms daily to reduce the size of the thyroid.

In most

instances this proved to be of a. distinct advantage.
Five patients who initially exhibited characteristics of
malignant excphthalmos, became worse after the first few weeks of
treatment.

One beoe;m.e very severe.

Desic<:rnted thyroid proved to

be benef'icia.l in the treatment of these cases.
The patients who received iodine therapy prior to thiouracil
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tended to be resistant to the latter drug.

A number of these patients

showed an elevation of basal metabolic rates for two weeks after the
transition from iodide to thiouracil.

Eventually all were benefited

from thiouracil.
.t;,

thyroidectomy was perfo nned on 22 pe.tients subsequently

because ~~th some it was the method of choice initially while others
lived too far distruit for adequate medical supervision.
these had normal metabolic rates at the time of surgery.

All of

No

technical difficulties were encountered during surgery except for
slight increase in the vascularity of the glands.

a

It was noted

that the patients who were treated with thiourea without iodide for
3 to 4 weeks prior to surgery had an extremely smooth postsurgical

course.
The first 30 patients in this study were treated with one gram
thiouracil per day as an initial dose.

All the subsequent patients

were started on 0.6 gram per day as an initial dose and a few 0.4

gram daily.

The maintenance dose was reduced to 0.l to 0.2 gram

daily.
Untoward reactions of some sort develo~ed in 13 of the 72 patients.
The most serious complication encountered was leukopenia with
agranulocytosis after 6 weeks of treatment during which time the
patient received 0.6 gra:m thiouracil daily for the first two weeks,
0.4 gram daily for the second two weeks., and

the next two weeks.

o. 2

gram daily during

Four others developed morbelliform rash which

cleared up in spite of the treatment.

Six patients developed

swelling of the legs unassociated with aIJ.y organic disease, but this
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likewise disappeared without discontinuance of thiouracil.

Two

others exnerienced nausea. and vomiting. end one, swelling of the
submaxillary glands.
Since J;:;nua.ry 1944, McGregor treated 20 cases of hyperthyroidism
with thiouracil end concluded that:
1.

Thiouracil lowered the metabolic rate faster then
iodine in the form of Lugol's.

2.

A feeling of improvement occurred within a few days
after thiouracil.

3.

Some patients a.re a.s well within 6 weeks a.s if they
had been thyroidectomized.

4.

The drug was ideal for postoperative recurrent
hyperthyroidism.

5.

It is a.n ideal treatment for -oatients who a.re poor
operative risks.

6.

Previous iodine therapy retarded the effect of thiouracil.

7.

No ill effeots were observed from the drug.
white blood count was 4,500.

Lowest

Nine typical case histories were reported. three of which were
picked e_t random and a.re summa.ri zed below:
Case 1.

Miss

o. c.,

age 23.

Outpatient April 22, 1944

Symptoms: Shortness of breath, nervousness. 6 pounds
--weiglit- loss, swelling of feet.
Pas~ ~is_t?_ry:

Rheumatic heart disease.

Physical Findings: Weight 114. Thyroid diffusely
-·enYarged, pulse 120, heart enlarged, murmur, coarse
and fine tremors, no exophthalmos.
Laboratory:
-per -cent-.

B. M. R. +25, serum cholesterol 200 mgm.

Treatment: Thiouracil 0.4 gram daily for 2 weeks,
-at~ tne- end of which time B. M. R. -1, pulse 74.
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Case 4•

Mrs. W• D• age 50.

March 6., 1944

Symptoms: Nervousness, shortness of breath, heat intolerance,
-enlarged thyroid.
FindiA~~s.: Ex~remely nervous, adenomatous thyroid., blood
pressure 160~88., pulse 112., blood cholesterol 104 mgm.
per cent.
Treatment:

Thiouracil 0.6 gralll per day for one week• .
better. Dose changed to 0.4 gram daily during
the second week. Third week B. M. R. + 31, pulse 106.
Patient reported much improved. Thiouracil dose reduced
to 0.2 gram daily. April 20. B. M. R. +13, pulse 90.
May 18. All clinical symptoms he.ve disappeared. 'White
blood count 7,200.

-sre·eping·

Case

a.

Mrs. J.B. age 41.

January 20, 1944

Symptoms: Heart pounding., extreme nervousness, heat
-in~orerence, quadriceps weak.
Findings: Marked exophthalmos, Blood pressure
. purs·e· t32, B. M. R. + 64. Swee.ting.

190/86.,

Treatment:
Jan. 20.

Thiouracil 0.6 gr8.lll daily

Mar. 10. General improvement includi~g decreased
exophthalmos. B. M. R. +36, blood cholesterol 82 mgms.
per cent. S8llle dosage continued •
May 5.

pounds.
June 2

B. M. R. + 37, pulse normal., weight gain 11
Dose thiouracil reduced to O.l gralll daily.
B. M. R. + 13, net gain 16 pounds.

Martin (203) reported 6 cases of thyrotoxicosis treated with
thiouracil.

The clinical results were most satisfying, a little

short of being miraculous.
1.2 gram to 0.1 gram daily.

Thiouracil was administered in doses of
No toxic symptoms were observed.

Watson and Wilcox treated 11 patients with thyrotoxicosis.

All

of these patients with an exception of one carried on their treatments
at home.

In most instances initial doses of 0.6 gram de.ily of
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thiouracil was used, and this was reduced ss improvement developed.
In 9 out of 11 patients definite clinical improvement followed
intake of the drug.
the patients.

No symptoms of toxicity developed in any of

The following table shows the typical responses to

thiouracil by three of the eleven cases presented in his report.

Date
No .. 1
Feb. 23,
Feb. 25
Mar. 15
Mar. 17
Mar. 23

Mar.
Apr.
Apr.
June

30
13
27
2

Basal.
Metabolic
Rate
+46
+49
+57
+51
+39

Resting
Pulse Rate Weight
106
106
114
120
100

130
131
136
135
137
141
155
155
151

+29

+ 2
+ 6
- 6

80
78
74

Blood
Cholesterol

211
276
248
230
233

I

I

I

Thiouracil
Daily Dosage

0.6 Gm.
i:

0.4 Gm.
0.2 Gm.

t

'
I

1·

[

!.

!

No. 2

~;

Dec.
Dec.
Dec.
Dec.
Jan.
Jan.
Apr.
Apr.
May
May

3
13
22
29
12
26
19
26
3
17

+65
+57
+34
+23
+35
+ll

+27
+30
+17
+16

135
100
90

84
76
78
94

88
84
70

126
125
126

214

134
138
144
147
146
149

250

104
106
109
127
132
126

188

I

0.6 Gm.

238
289
292
277

0.3 Gm..

0.2 Gm.
0.3 Gm.

No. 3
Nov.
Nov.
Dec.
Mar.
May
June

10
25
2
14
12
2

+70
+26
+21
+21
- 3
+ 2

98
94
90
86
88

72

194

266
253
210

0.6 Gm.

0.2 Gm.
0.1 Gm.

Grollman and Gryte used thiouracil in the treatment of 18
patients with thyrotoxicosis with results compe.rable to those
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obtained by other workers.

Satisfactory responses were observed

in all but one patient with nodular goiter of 20 years duration.
This patient was treated previously with iodine and was admitted
in a thyroid storm.

Four patients developed mild urticarial reactions

2 or 3 days after beginning of therapy but this subsided without
interruption of treatment.

In 4 other pa.ti ents a drop of

leukocytes from a 6000 to 10.000 level down to 3000 to 4000 was
found but no further decline occurred when the dose of thiouracil
was reduced to 0.4 gram daily from the initial dose of 0.6 gram
daily.

'.l:ne drug also was found to be superior to iodine in preoperative

preparation of patients with toxic a.denomas.
Reveno reported 9 cases or toxic adenomas treated with thiouracil
over a period of 8 months.

Five of these had been taking Lugol 1 s

solution immediately preceding treatment.
in doses of

o.8

gram to 0.4 gram daily.

Thiouracil was administered
The daily dose was reduced

as improvement occurred.
Six patients showed definite improvement characterized by
lowered basal metabolic rates, lowered pulse rates, and gain in body
weight.

Some softening of the thyroid glands were noted in most

instances.

The results were reported as good as those following a

successful thyroidectomy.
In one of the patients, there was a p~omise of improvement which
fe_iled to materialize because of lack of cooperation.

Another

patient in whom diabetes mellitus coexisted vdth thyrotoxicosis
had received iodine for 6 months previously, end ftlled to respond

J

!l

to thiouracil.

The tr~rd patient develo~ed a hemorrhage into the

I
I

gland and was subjected to surgery.

!

Ii
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Mild gastric distress in the form of pain, burning

e,rl

gnawing

was rep:Jrted e.t ·c;:,-.: onset of treE,tment in nme pet~ f'lnts but -shis

Vv'f.l.S

~ontrolled by ta.king food with the drug.
Rose and McConnell used th1ouracil in the treatment of 37
patients with thyrotoxicosis.

Thirty patients (81 per cent) showed

a definite improvement as was reflected by decline

in the basal meta-

bolic rate, decreased heart rate., gain in weight, e.nd improvement
in subjective symptoms.

In 4 patients (10.9 per cent) there was a

partial improvement and 2 patients (5.4 per cent) failed completely
to respond to the drug.
Among the 30 ne,tients with favorable response, 11 remained
~~bulatory while the remainder were hospitalized for periods of 1
to 3 weeks at the beginning of the treatment.

Average time required

for the basal metabolic rate to fall to +15 or below was 2~ weeks.
In 6 of these patients whose initial basal metabolic rate was+ 50
or higher, the average duration of therapy before 'j:;he metabolic
rate was reduced to~ 15 or lower was 3+ weeks.
Three patients showed relapses when the drug was reduced to
0.2 gram daily e.nd in 10 others relapse occurred in 1 to 4 weeks when

the drug was vv'i. thdra.wn.
0.4 to 1 gram daily.

However, al 1 :responded a.gain to doses of

Three of the 18.tter patients were reported

subsequently well for periods of 1 to 4 months after complete
withdrawal of the drug.
Thiouracil wa.R administered in doses of
doses daily for the first three days.

o.e grem

in divided

If no untoward reaction

occurred, the dose was increased to 0,. 8 to 1 gram daily in divided
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doses and a maximum dose was maintained until remission began to
e:pnear or when it beoeme apparent that no response could be expected.
The dose was then gradually reduced to 0.1 to 0.2 gram daily when
the be_se.1 metabolic rate beceme normal.

The patients were maintained

on this dose for a period of one month and the drug was then withdrawn.

In addition, thiouracil was used in the preoperative preparation
of 3 patients for subtotal thyroideotomies.

In these patients

hospitalization was necessary for 17, 21, and 28 days before the
basal metabolic rates were lowered to+ 15 or below.
The gross appearance of the thyroid at operation differed
markedly from those observed in patients treated preoperatively
with iodine.

There was no reduction in the size of the goiter, end

the thyroids were friable, vascular and bled easily.

Microscopically

there was observed a marked persista.nt hyperplasia similar in
apnearance to untreated toxic thyroid.

(Fig. 12)

The most serious complication consisted of leukopenia,
pharyngitis, and fever in two patients.
blood oount dropped to 1200.
was

discontinued.

In one of these the white

All symptoms disappeared when the drug

In 14 others the leukocyte count decreased to

below 5000, and in 6 of these it returned to normal without interruption of therapy.
Control of thyrotoxicosis with thiouracil in a 13 year old girl
with diabetes mellitus was also reported by these WDrkers.

No

change appeared in either her carbohydrate tolerance or insulin
requirement.
Nussey treated 27 patients at the Selly Oak Hospital for
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periods of 2 to 11 weeks with an average of 3 weeks.

During the

time of teatment all other drugs were discontinued, not even a
sedative was allowed.

The i~itial doses ·of thiouracil consisted

of 0.2 gram, three times daily for 3 to 5 weeks after which the
dose was reduced and kept at the lowest possible level com.pa~ible
with well being.

Most of them were maintained on doses of 0.2 gram

daily, and some on 0.05 to O.l gram d!dly for 2 to 4

weeks after

leaving the hospital.

Fig. 12 Left. Histological appearance of a hyperplastic
thyroid before operation. (Biopsy)
.

Right. Same gland after 23 days on thiouracil.
(Thyroidectomy) From Rose and McConnell
Signs of improvement were observed in 10 to 14 days.

Sever~

oases of thyrotoxicosis responded as quickly as the milder cases.
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Restlessness was the first symptom to disnppear.

This was followed

by disap[)ea.rance of sweating and tremor, increase of weight, and

decrease in basal metnbolic and pulse rates.

Exophthalmos and the

size of the thyroid were not influenced materially.
Exelllination of the blood showed an ini tie.l decrease in the
leukocyte count ~~th some bordering on frank leukopenia, but in
some the leukocyte count beceme normal as the treatment progressed.
The latest experience is reported by Eaton who has treated 40
cases and 36 had systematic records of progress made.

The 36 cases

comprised 28 toxic diffuse goiters, 4 toxic nodular ~oiters, and 4
with recurrent thyrotoxicosis.

Five were males and 31 females.

Four had coincident diabetes mellitus.
part of the treatment.

Twc were pregnant during

The age of onset v~ried from 16 to 64 years

with a mean of 38 years.
All except one who was a diabetic, responded favorably.

The

effects were found to be similar in males end females, and at all
ages.

Exophthalmos when present was not appreciably affected, al-

though in a few cases it di!"j_ni shed.
dur::::;; the treo-i:;:rrH''nt.

In sc:;:;.e., the goiters .,,nlarged

The mee.n circumf'ere:,cP of the neok before

treatment was 32.4 cm. and a....t>ter treatment 32. 9 cm.

Four patients

who were previously treated with iodine failed to respond to
thiouracil until several weeks after the trea.tment ha.d been started.
Seven patients remained well for periods of

5½

to 8 months after

the drug was discontinued.
Of the 4 diabetic patients, 3 with primary diabetes responded
well to thiouracil.

The one in whom thyrotoxicosis was the primary

disease failed to respond.
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Pregnancy we.s not in any way affected by the tree.tment exoept

that one child ha.d an enlarged thyroid at birth.
well and progressed normally.

The child fed

The enlargement subsided by the end

of 3 months~
No appreciable toxic effects were observed in any of the
patients.

Some developed a. lowered white count~ but this was

followed bye. rise even though the treatment was continued.

One

patient developed e.granulocytosis while taking 0.2 gram thiouracil
daily.

'Ihe count returned to normal after wi thdre.'\'Bl of the drug.
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C ONCL US I ON S

CONCLUSIONS
Thyrotoxicosis is a for;n, of thyroid disease of unknown origin
which exhibits toxicity in widely different degrees.

The thyroid

is believed to be only a link in the disease process since there
appears to be a close rele.tionship between the thyroid, other
endocrine glands, and the autonomic nervous system.
There is no specific treatment for thyrotoxicosis.

Surgery

is usually a time saving procedure in uncomplicated cases.

Roentgen

ray treatment has been shown to give as good results as those
obtained from thyroidectomy.
Thiouracil probably offers the greatest hope in the nonoperative
treRtment of all forms of thyrotoxicosis.

The results in the

majority of the oases are Sfid to be as effective as those following
a successful thyroidectomy.

The drug is also reported to be

superior to iodine in the preoperative management of patients.
The use of desiccated thyroid was pointed out to be beneficial
in bringing about a regression of the thyroid~ and a recession of
the exophthalmos when present.
Leukopenia and agre.nulocytosis are the most serious complications of thiouracil there.PY•

Freauent blood counts are necessary to

guard against these untoward results.
Sufficient time has not elapsed for proper evaluation of the
results of thiouracil therapy.
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